'en:lelomyosarcoma'
(id=15690896 ; fe=en:lelomyosarcoma ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=17225 creation date=2020-11-12 touchdate=2025-12-16 11:27:11.000) ≈ 693 relations sortantes
- en:lelomyosarcoma --
r_associated #0: 47 / 1 ->
sarcome
n1=en:lelomyosarcoma | n2=sarcome | rel=r_associated | relid=0 | w=47
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
cancer
n1=en:lelomyosarcoma | n2=cancer | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
cancérologie
n1=en:lelomyosarcoma | n2=cancérologie | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
carcinologie
n1=en:lelomyosarcoma | n2=carcinologie | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
carcinologie
(oncologie)
n1=en:lelomyosarcoma | n2=carcinologie (oncologie) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
cellule musculaire lisse
n1=en:lelomyosarcoma | n2=cellule musculaire lisse | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
cellules musculaires lisses
n1=en:lelomyosarcoma | n2=cellules musculaires lisses | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:acinar cell carcinoma
n1=en:lelomyosarcoma | n2=en:acinar cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:acral lentiginous melanoma
n1=en:lelomyosarcoma | n2=en:acral lentiginous melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adamantinoma
n1=en:lelomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adenocarcinoma in adenomatous polyp
n1=en:lelomyosarcoma | n2=en:adenocarcinoma in adenomatous polyp | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adenocarcinoma in villous adenoma
n1=en:lelomyosarcoma | n2=en:adenocarcinoma in villous adenoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adenomyoepithelioma with carcinoma
n1=en:lelomyosarcoma | n2=en:adenomyoepithelioma with carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adenosarcoma
n1=en:lelomyosarcoma | n2=en:adenosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adenosquamous carcinoma
n1=en:lelomyosarcoma | n2=en:adenosquamous carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:adnexal carcinoma
n1=en:lelomyosarcoma | n2=en:adnexal carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:alpha heavy chain disease
n1=en:lelomyosarcoma | n2=en:alpha heavy chain disease | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:alveolar rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:alveolar rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:alveolar soft part sarcoma
n1=en:lelomyosarcoma | n2=en:alveolar soft part sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:amelanotic melanoma
n1=en:lelomyosarcoma | n2=en:amelanotic melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ameloblastic fibrosarcoma
n1=en:lelomyosarcoma | n2=en:ameloblastic fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ameloblastic odontosarcoma
n1=en:lelomyosarcoma | n2=en:ameloblastic odontosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:anal canal cloacogenic carcinoma
n1=en:lelomyosarcoma | n2=en:anal canal cloacogenic carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:anal leiomyoma
n1=en:lelomyosarcoma | n2=en:anal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:anaplastic (malignant) meningioma
n1=en:lelomyosarcoma | n2=en:anaplastic (malignant) meningioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:anaplastic ganglioglioma
n1=en:lelomyosarcoma | n2=en:anaplastic ganglioglioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:angioleiomyoma
n1=en:lelomyosarcoma | n2=en:angioleiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:angiomyoliposarcoma
n1=en:lelomyosarcoma | n2=en:angiomyoliposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:angiomyosarcoma
n1=en:lelomyosarcoma | n2=en:angiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:angiosarcoma
n1=en:lelomyosarcoma | n2=en:angiosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:appendix leiomyoma
n1=en:lelomyosarcoma | n2=en:appendix leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:askin tumor
n1=en:lelomyosarcoma | n2=en:askin tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:aspects of radionuclide imaging
n1=en:lelomyosarcoma | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:atypical medullary carcinoma
n1=en:lelomyosarcoma | n2=en:atypical medullary carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:balloon cell melanoma
n1=en:lelomyosarcoma | n2=en:balloon cell melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:basaloid carcinoma
n1=en:lelomyosarcoma | n2=en:basaloid carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:benign muscle neoplasm
n1=en:lelomyosarcoma | n2=en:benign muscle neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:benign myomatous tumor
n1=en:lelomyosarcoma | n2=en:benign myomatous tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:bladder leiomyoma
n1=en:lelomyosarcoma | n2=en:bladder leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:blood supply aspects
n1=en:lelomyosarcoma | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:bone leiomyoma
n1=en:lelomyosarcoma | n2=en:bone leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:bone sarcoma
n1=en:lelomyosarcoma | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:burkitt leukemia
n1=en:lelomyosarcoma | n2=en:burkitt leukemia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinofibroma
n1=en:lelomyosarcoma | n2=en:carcinofibroma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinoma
n1=en:lelomyosarcoma | n2=en:carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinoma of bone, connective tissue, skin and breast
n1=en:lelomyosarcoma | n2=en:carcinoma of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinoma of lip, oral cavity and pharynx
n1=en:lelomyosarcoma | n2=en:carcinoma of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinoma with osteoclast-like giant cells
n1=en:lelomyosarcoma | n2=en:carcinoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinosarcoma
n1=en:lelomyosarcoma | n2=en:carcinosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carcinosarcoma, embryonal
n1=en:lelomyosarcoma | n2=en:carcinosarcoma, embryonal | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:carney triad
n1=en:lelomyosarcoma | n2=en:carney triad | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cdisc send terminology
n1=en:lelomyosarcoma | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cdisc send tumor findings results terminology
n1=en:lelomyosarcoma | n2=en:cdisc send tumor findings results terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cellular secretion
n1=en:lelomyosarcoma | n2=en:cellular secretion | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:central nervous system leiomyoma
n1=en:lelomyosarcoma | n2=en:central nervous system leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cervical leiomyoma
n1=en:lelomyosarcoma | n2=en:cervical leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chemical aspects
n1=en:lelomyosarcoma | n2=en:chemical aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chondroblastic osteosarcoma
n1=en:lelomyosarcoma | n2=en:chondroblastic osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chondroblastoma, malignant
n1=en:lelomyosarcoma | n2=en:chondroblastoma, malignant | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chondroid chordoma
n1=en:lelomyosarcoma | n2=en:chondroid chordoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chondrosarcoma
n1=en:lelomyosarcoma | n2=en:chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chordoma
n1=en:lelomyosarcoma | n2=en:chordoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:choriocarcinoma combined with other germ cell elements
n1=en:lelomyosarcoma | n2=en:choriocarcinoma combined with other germ cell elements | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:choroidal leiomyoma
n1=en:lelomyosarcoma | n2=en:choroidal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:chronic myelomonocytic leukemia
n1=en:lelomyosarcoma | n2=en:chronic myelomonocytic leukemia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:classic kaposi sarcoma
n1=en:lelomyosarcoma | n2=en:classic kaposi sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:clear cell chondrosarcoma
n1=en:lelomyosarcoma | n2=en:clear cell chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:clear cell sarcoma of the kidney
n1=en:lelomyosarcoma | n2=en:clear cell sarcoma of the kidney | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:clinical data interchange standards consortium terminology
n1=en:lelomyosarcoma | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:colorectal leiomyoma
n1=en:lelomyosarcoma | n2=en:colorectal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:combined small cell lung carcinoma
n1=en:lelomyosarcoma | n2=en:combined small cell lung carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:complication aspects
n1=en:lelomyosarcoma | n2=en:complication aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:composite hodgkin and non-hodgkin lymphoma
n1=en:lelomyosarcoma | n2=en:composite hodgkin and non-hodgkin lymphoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:congenital mesh qualifier
n1=en:lelomyosarcoma | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:connective and soft tissue
n1=en:lelomyosarcoma | n2=en:connective and soft tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:connective and soft tissue cell
n1=en:lelomyosarcoma | n2=en:connective and soft tissue cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:conventional osteosarcoma
n1=en:lelomyosarcoma | n2=en:conventional osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cutaneous leiomyoma
n1=en:lelomyosarcoma | n2=en:cutaneous leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:cystic partially differentiated nephroblastoma
n1=en:lelomyosarcoma | n2=en:cystic partially differentiated nephroblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:dedifferentiated chondrosarcoma
n1=en:lelomyosarcoma | n2=en:dedifferentiated chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:dedifferentiated chordoma
n1=en:lelomyosarcoma | n2=en:dedifferentiated chordoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:dedifferentiated liposarcoma
n1=en:lelomyosarcoma | n2=en:dedifferentiated liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:deep leiomyoma
n1=en:lelomyosarcoma | n2=en:deep leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:del(13q12-13)
n1=en:lelomyosarcoma | n2=en:del(13q12-13) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:del(13q32-qter)
n1=en:lelomyosarcoma | n2=en:del(13q32-qter) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:del(3p21-23)
n1=en:lelomyosarcoma | n2=en:del(3p21-23) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:del(8p21-pter)
n1=en:lelomyosarcoma | n2=en:del(8p21-pter) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:dermatofibrosarcoma protuberans
n1=en:lelomyosarcoma | n2=en:dermatofibrosarcoma protuberans | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:desmoid-type fibromatosis
n1=en:lelomyosarcoma | n2=en:desmoid-type fibromatosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:desmoplastic mesothelioma
n1=en:lelomyosarcoma | n2=en:desmoplastic mesothelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:desmoplastic small round cell tumor
n1=en:lelomyosarcoma | n2=en:desmoplastic small round cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:diffuse embryoma
n1=en:lelomyosarcoma | n2=en:diffuse embryoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:duct carcinoma, desmoplastic type
n1=en:lelomyosarcoma | n2=en:duct carcinoma, desmoplastic type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ductal carcinoma
n1=en:lelomyosarcoma | n2=en:ductal carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:eccrine adenocarcinoma
n1=en:lelomyosarcoma | n2=en:eccrine adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:eccrine porocarcinoma
n1=en:lelomyosarcoma | n2=en:eccrine porocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ectomesenchymoma
n1=en:lelomyosarcoma | n2=en:ectomesenchymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:embryologic
n1=en:lelomyosarcoma | n2=en:embryologic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:embryonal rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:embryonal rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:embryonal tumor with multilayered rosettes, c19mc-altered
n1=en:lelomyosarcoma | n2=en:embryonal tumor with multilayered rosettes, c19mc-altered | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:encapsulated papillary carcinoma with invasion
n1=en:lelomyosarcoma | n2=en:encapsulated papillary carcinoma with invasion | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:endometrial stromal sarcoma - category
n1=en:lelomyosarcoma | n2=en:endometrial stromal sarcoma - category | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:endometrial stromal tumors
n1=en:lelomyosarcoma | n2=en:endometrial stromal tumors | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelial cell
n1=en:lelomyosarcoma | n2=en:epithelial cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelial tissue
n1=en:lelomyosarcoma | n2=en:epithelial tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelial-myoepithelial carcinoma
n1=en:lelomyosarcoma | n2=en:epithelial-myoepithelial carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid cell melanoma
n1=en:lelomyosarcoma | n2=en:epithelioid cell melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid cell type gastrointestinal stromal tumor
n1=en:lelomyosarcoma | n2=en:epithelioid cell type gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:epithelioid leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid malignant peripheral nerve sheath tumor
n1=en:lelomyosarcoma | n2=en:epithelioid malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid mesothelioma
n1=en:lelomyosarcoma | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid sarcoma
n1=en:lelomyosarcoma | n2=en:epithelioid sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:epithelioid trophoblastic tumor
n1=en:lelomyosarcoma | n2=en:epithelioid trophoblastic tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:essential thrombocythemia
n1=en:lelomyosarcoma | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:etiology aspects
n1=en:lelomyosarcoma | n2=en:etiology aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ewing sarcoma
n1=en:lelomyosarcoma | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ewing sarcoma/peripheral primitive neuroectodermal tumor
n1=en:lelomyosarcoma | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:exposure as collected domain
n1=en:lelomyosarcoma | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extrahepatic bile duct leiomyoma
n1=en:lelomyosarcoma | n2=en:extrahepatic bile duct leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extramammary paget disease
n1=en:lelomyosarcoma | n2=en:extramammary paget disease | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extrarenal rhabdoid tumor
n1=en:lelomyosarcoma | n2=en:extrarenal rhabdoid tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extraskeletal chondrosarcoma recurrent
n1=en:lelomyosarcoma | n2=en:extraskeletal chondrosarcoma recurrent | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extraskeletal ewing sarcoma
n1=en:lelomyosarcoma | n2=en:extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:extraskeletal myxoid chondrosarcoma
n1=en:lelomyosarcoma | n2=en:extraskeletal myxoid chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fallopian tube leiomyoma
n1=en:lelomyosarcoma | n2=en:fallopian tube leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:familial letterer-siwe disease
n1=en:lelomyosarcoma | n2=en:familial letterer-siwe disease | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fascial fibrosarcoma
n1=en:lelomyosarcoma | n2=en:fascial fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fetal rhabdomyoma
n1=en:lelomyosarcoma | n2=en:fetal rhabdomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fibroblastic liposarcoma
n1=en:lelomyosarcoma | n2=en:fibroblastic liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fibroblastic osteosarcoma
n1=en:lelomyosarcoma | n2=en:fibroblastic osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fibroma
n1=en:lelomyosarcoma | n2=en:fibroma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:fibrosarcoma
n1=en:lelomyosarcoma | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:follicular dendritic cell sarcoma
n1=en:lelomyosarcoma | n2=en:follicular dendritic cell sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:follicular dendritic sarcoma of lymph nodes of multiple sites
n1=en:lelomyosarcoma | n2=en:follicular dendritic sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 1
n1=en:lelomyosarcoma | n2=en:gain of chromosome 1 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 15
n1=en:lelomyosarcoma | n2=en:gain of chromosome 15 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 17
n1=en:lelomyosarcoma | n2=en:gain of chromosome 17 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 19
n1=en:lelomyosarcoma | n2=en:gain of chromosome 19 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 1q21-31
n1=en:lelomyosarcoma | n2=en:gain of chromosome 1q21-31 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome 22
n1=en:lelomyosarcoma | n2=en:gain of chromosome 22 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gain of chromosome x
n1=en:lelomyosarcoma | n2=en:gain of chromosome x | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ganglioneuroblastoma
n1=en:lelomyosarcoma | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:gastric leiomyoma
n1=en:lelomyosarcoma | n2=en:gastric leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:genetic aspects
n1=en:lelomyosarcoma | n2=en:genetic aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:genital rhabdomyoma
n1=en:lelomyosarcoma | n2=en:genital rhabdomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:germinoma
n1=en:lelomyosarcoma | n2=en:germinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:giant cell sarcoma
n1=en:lelomyosarcoma | n2=en:giant cell sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:giant cell sarcoma (except of bone, m-92503)
n1=en:lelomyosarcoma | n2=en:giant cell sarcoma (except of bone, m-92503) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:glassy cell carcinoma
n1=en:lelomyosarcoma | n2=en:glassy cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:glioblastoma
n1=en:lelomyosarcoma | n2=en:glioblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:granular cell tumor
n1=en:lelomyosarcoma | n2=en:granular cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:granulocytic sarcoma
n1=en:lelomyosarcoma | n2=en:granulocytic sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:heavy chain disease
n1=en:lelomyosarcoma | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:hepatoblastoma
n1=en:lelomyosarcoma | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:hepatoid adenocarcinoma
n1=en:lelomyosarcoma | n2=en:hepatoid adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:high grade serous carcinoma
n1=en:lelomyosarcoma | n2=en:high grade serous carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:high grade surface osteosarcoma
n1=en:lelomyosarcoma | n2=en:high grade surface osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:histiocytic sarcoma
n1=en:lelomyosarcoma | n2=en:histiocytic sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:historical aspects qualifier
n1=en:lelomyosarcoma | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:hodgkin lymphoma
n1=en:lelomyosarcoma | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:hypereosinophilic syndrome
n1=en:lelomyosarcoma | n2=en:hypereosinophilic syndrome | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:idiopathic hypereosinophilic syndrome
n1=en:lelomyosarcoma | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:immunology aspects
n1=en:lelomyosarcoma | n2=en:immunology aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:in blood
n1=en:lelomyosarcoma | n2=en:in blood | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:in cerebrospinal fluid
n1=en:lelomyosarcoma | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:in urine
n1=en:lelomyosarcoma | n2=en:in urine | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:indolent systemic mastocytosis
n1=en:lelomyosarcoma | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:infantile fibrosarcoma
n1=en:lelomyosarcoma | n2=en:infantile fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:infiltrating carcinoma with ductal and lobular features
n1=en:lelomyosarcoma | n2=en:infiltrating carcinoma with ductal and lobular features | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:infiltrating duct mixed with other types of carcinoma
n1=en:lelomyosarcoma | n2=en:infiltrating duct mixed with other types of carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:infiltrating lobular mixed with other types of carcinoma
n1=en:lelomyosarcoma | n2=en:infiltrating lobular mixed with other types of carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:intermediate filaments present
n1=en:lelomyosarcoma | n2=en:intermediate filaments present | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:intracytoplasmic eosinophilic inclusion
n1=en:lelomyosarcoma | n2=en:intracytoplasmic eosinophilic inclusion | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:intraductal papillary adenocarcinoma with invasion
n1=en:lelomyosarcoma | n2=en:intraductal papillary adenocarcinoma with invasion | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:invasive ductal and lobular carcinoma in situ
n1=en:lelomyosarcoma | n2=en:invasive ductal and lobular carcinoma in situ | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:invasive ductal carcinoma, not otherwise specified
n1=en:lelomyosarcoma | n2=en:invasive ductal carcinoma, not otherwise specified | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:invasive micropapillary breast carcinoma
n1=en:lelomyosarcoma | n2=en:invasive micropapillary breast carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:kidney sarcoma
n1=en:lelomyosarcoma | n2=en:kidney sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:kidney wilms tumor
n1=en:lelomyosarcoma | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:langerhans cell histiocytosis
n1=en:lelomyosarcoma | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:large cell lung carcinoma with rhabdoid phenotype
n1=en:lelomyosarcoma | n2=en:large cell lung carcinoma with rhabdoid phenotype | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:large cell neuroendocrine carcinoma
n1=en:lelomyosarcoma | n2=en:large cell neuroendocrine carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:laryngeal leiomyoma
n1=en:lelomyosarcoma | n2=en:laryngeal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyoma
n1=en:lelomyosarcoma | n2=en:leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyoma of iris
n1=en:lelomyosarcoma | n2=en:leiomyoma of iris | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyomatous neoplasm - category
n1=en:lelomyosarcoma | n2=en:leiomyomatous neoplasm - category | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma - category
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma - category | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma of the mouse intestinal tract
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse intestinal tract | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma of the mouse nose and paranasal sinuses
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse nose and paranasal sinuses | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma of the mouse oral cavity
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse oral cavity | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma of the mouse prostate gland
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse prostate gland | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leiomyosarcoma of the mouse skin
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse skin | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:lentigo maligna melanoma
n1=en:lelomyosarcoma | n2=en:lentigo maligna melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leukemia
n1=en:lelomyosarcoma | n2=en:leukemia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:leukemia (category)
n1=en:lelomyosarcoma | n2=en:leukemia (category) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:liposarcoma of connective tissue
n1=en:lelomyosarcoma | n2=en:liposarcoma of connective tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:liver leiomyoma
n1=en:lelomyosarcoma | n2=en:liver leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:liver sarcoma
n1=en:lelomyosarcoma | n2=en:liver sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:low grade central osteosarcoma
n1=en:lelomyosarcoma | n2=en:low grade central osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:low grade serous carcinoma
n1=en:lelomyosarcoma | n2=en:low grade serous carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:lung leiomyoma
n1=en:lelomyosarcoma | n2=en:lung leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:lymphosarcoma
n1=en:lelomyosarcoma | n2=en:lymphosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:lymphosarcoma of lymph nodes of head, face and neck
n1=en:lelomyosarcoma | n2=en:lymphosarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:lymphosarcoma of lymph nodes of multiple sites
n1=en:lelomyosarcoma | n2=en:lymphosarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignancy in giant cell tumor of bone
n1=en:lelomyosarcoma | n2=en:malignancy in giant cell tumor of bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant adrenal gland pheochromocytoma
n1=en:lelomyosarcoma | n2=en:malignant adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant carotid body paraganglioma
n1=en:lelomyosarcoma | n2=en:malignant carotid body paraganglioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant cell
n1=en:lelomyosarcoma | n2=en:malignant cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant extra-adrenal paraganglioma
n1=en:lelomyosarcoma | n2=en:malignant extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant giant cell neoplasm
n1=en:lelomyosarcoma | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant granular cell tumor
n1=en:lelomyosarcoma | n2=en:malignant granular cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant immunoproliferative disease (clinical)
n1=en:lelomyosarcoma | n2=en:malignant immunoproliferative disease (clinical) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant immunoproliferative neoplasm
n1=en:lelomyosarcoma | n2=en:malignant immunoproliferative neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant joint neoplasm
n1=en:lelomyosarcoma | n2=en:malignant joint neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant leydig cell tumor
n1=en:lelomyosarcoma | n2=en:malignant leydig cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mast cell neoplasm
n1=en:lelomyosarcoma | n2=en:malignant mast cell neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant melanoma in giant pigmented nevus
n1=en:lelomyosarcoma | n2=en:malignant melanoma in giant pigmented nevus | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant melanoma in precancerous melanosis
n1=en:lelomyosarcoma | n2=en:malignant melanoma in precancerous melanosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mesenchymoma
n1=en:lelomyosarcoma | n2=en:malignant mesenchymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mesenchymoma metastatic
n1=en:lelomyosarcoma | n2=en:malignant mesenchymoma metastatic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mesenchymoma recurrent
n1=en:lelomyosarcoma | n2=en:malignant mesenchymoma recurrent | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mixed neoplasm
n1=en:lelomyosarcoma | n2=en:malignant mixed neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mixed tumor, carcinomatous type
n1=en:lelomyosarcoma | n2=en:malignant mixed tumor, carcinomatous type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant mixed tumor, osteosarcomatous type
n1=en:lelomyosarcoma | n2=en:malignant mixed tumor, osteosarcomatous type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant muscle neoplasm
n1=en:lelomyosarcoma | n2=en:malignant muscle neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant musculoskeletal and connective tissue neoplasms
n1=en:lelomyosarcoma | n2=en:malignant musculoskeletal and connective tissue neoplasms | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant neoplasm of connective tissue
n1=en:lelomyosarcoma | n2=en:malignant neoplasm of connective tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant neoplasm of nail apparatus
n1=en:lelomyosarcoma | n2=en:malignant neoplasm of nail apparatus | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant neoplasm, overlapping lesion of digestive system
n1=en:lelomyosarcoma | n2=en:malignant neoplasm, overlapping lesion of digestive system | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant neuroendocrine neoplasm, neural
n1=en:lelomyosarcoma | n2=en:malignant neuroendocrine neoplasm, neural | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant odontogenic ghost cell tumor
n1=en:lelomyosarcoma | n2=en:malignant odontogenic ghost cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant odontogenic neoplasm
n1=en:lelomyosarcoma | n2=en:malignant odontogenic neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant ossifying fibromyxoid tumor
n1=en:lelomyosarcoma | n2=en:malignant ossifying fibromyxoid tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant ovarian brenner tumor
n1=en:lelomyosarcoma | n2=en:malignant ovarian brenner tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant ovarian thecoma
n1=en:lelomyosarcoma | n2=en:malignant ovarian thecoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant pecoma
n1=en:lelomyosarcoma | n2=en:malignant pecoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant peripheral nerve sheath tumor
n1=en:lelomyosarcoma | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant sebaceous neoplasm
n1=en:lelomyosarcoma | n2=en:malignant sebaceous neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant smooth muscle cell
n1=en:lelomyosarcoma | n2=en:malignant smooth muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant soft tissue neoplasm
n1=en:lelomyosarcoma | n2=en:malignant soft tissue neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant solitary fibrous tumor
n1=en:lelomyosarcoma | n2=en:malignant solitary fibrous tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant spindle cell neoplasm
n1=en:lelomyosarcoma | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant spindle-shaped smooth muscle cell
n1=en:lelomyosarcoma | n2=en:malignant spindle-shaped smooth muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant squamous cell neoplasm
n1=en:lelomyosarcoma | n2=en:malignant squamous cell neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant struma ovarii
n1=en:lelomyosarcoma | n2=en:malignant struma ovarii | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant tenosynovial giant cell tumor
n1=en:lelomyosarcoma | n2=en:malignant tenosynovial giant cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant triton tumor
n1=en:lelomyosarcoma | n2=en:malignant triton tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant trophoblastic teratoma
n1=en:lelomyosarcoma | n2=en:malignant trophoblastic teratoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant tumor, clear cell type
n1=en:lelomyosarcoma | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant tumor, small cell type
n1=en:lelomyosarcoma | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant type a thymoma
n1=en:lelomyosarcoma | n2=en:malignant type a thymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant type ab thymoma
n1=en:lelomyosarcoma | n2=en:malignant type ab thymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant type b1 thymoma
n1=en:lelomyosarcoma | n2=en:malignant type b1 thymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:malignant type b2 thymoma
n1=en:lelomyosarcoma | n2=en:malignant type b2 thymoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mast cell malignancy
n1=en:lelomyosarcoma | n2=en:mast cell malignancy | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mast cell sarcoma
n1=en:lelomyosarcoma | n2=en:mast cell sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:medullary carcinoma with lymphoid stroma
n1=en:lelomyosarcoma | n2=en:medullary carcinoma with lymphoid stroma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:medulloblastoma
n1=en:lelomyosarcoma | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:medulloepithelioma
n1=en:lelomyosarcoma | n2=en:medulloepithelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:melanoma
n1=en:lelomyosarcoma | n2=en:melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:melanoma arising from blue nevus
n1=en:lelomyosarcoma | n2=en:melanoma arising from blue nevus | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:melanoma in junctional nevus
n1=en:lelomyosarcoma | n2=en:melanoma in junctional nevus | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:meningeal melanomatosis
n1=en:lelomyosarcoma | n2=en:meningeal melanomatosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:meningeal sarcomatosis
n1=en:lelomyosarcoma | n2=en:meningeal sarcomatosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mesenchymal chondrosarcoma
n1=en:lelomyosarcoma | n2=en:mesenchymal chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mesonephric adenocarcinoma
n1=en:lelomyosarcoma | n2=en:mesonephric adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mesothelioma (malignant, clinical disorder) (disorder)
n1=en:lelomyosarcoma | n2=en:mesothelioma (malignant, clinical disorder) (disorder) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metabolic aspects
n1=en:lelomyosarcoma | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metaplastic carcinoma
n1=en:lelomyosarcoma | n2=en:metaplastic carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastasis to lymph node from adenocarcinoma
n1=en:lelomyosarcoma | n2=en:metastasis to lymph node from adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastasis to lymph node from squamous cell carcinoma
n1=en:lelomyosarcoma | n2=en:metastasis to lymph node from squamous cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastasizing ameloblastoma
n1=en:lelomyosarcoma | n2=en:metastasizing ameloblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic alveolar soft part sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic alveolar soft part sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic chondrosarcoma
n1=en:lelomyosarcoma | n2=en:metastatic chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic epithelioid sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic epithelioid sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic ewing sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic extraskeletal ewing sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic extraskeletal osteosarcoma
n1=en:lelomyosarcoma | n2=en:metastatic extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic fibrosarcoma
n1=en:lelomyosarcoma | n2=en:metastatic fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:metastatic leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic liposarcoma
n1=en:lelomyosarcoma | n2=en:metastatic liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic malignant neoplasm in the bone
n1=en:lelomyosarcoma | n2=en:metastatic malignant neoplasm in the bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic malignant neoplasm in the chest wall
n1=en:lelomyosarcoma | n2=en:metastatic malignant neoplasm in the chest wall | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic malignant neoplasm in the neck
n1=en:lelomyosarcoma | n2=en:metastatic malignant neoplasm in the neck | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic malignant neoplasm in the spine
n1=en:lelomyosarcoma | n2=en:metastatic malignant neoplasm in the spine | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic malignant peripheral nerve sheath tumor
n1=en:lelomyosarcoma | n2=en:metastatic malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic osteosarcoma
n1=en:lelomyosarcoma | n2=en:metastatic osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic peripheral primitive neuroectodermal tumor of bone
n1=en:lelomyosarcoma | n2=en:metastatic peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic qualifier
n1=en:lelomyosarcoma | n2=en:metastatic qualifier | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic synovial sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic synovial sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:metastatic undifferentiated pleomorphic sarcoma
n1=en:lelomyosarcoma | n2=en:metastatic undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:microbiological
n1=en:lelomyosarcoma | n2=en:microbiological | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:microcystic adnexal carcinoma
n1=en:lelomyosarcoma | n2=en:microcystic adnexal carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:micropapillary transitional cell carcinoma
n1=en:lelomyosarcoma | n2=en:micropapillary transitional cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:minimal deviation malignant melanoma
n1=en:lelomyosarcoma | n2=en:minimal deviation malignant melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed acinar-ductal carcinoma
n1=en:lelomyosarcoma | n2=en:mixed acinar-ductal carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed epithelioid and spindle cell melanoma
n1=en:lelomyosarcoma | n2=en:mixed epithelioid and spindle cell melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed glioma
n1=en:lelomyosarcoma | n2=en:mixed glioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed liposarcoma
n1=en:lelomyosarcoma | n2=en:mixed liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed tumor, mesodermal
n1=en:lelomyosarcoma | n2=en:mixed tumor, mesodermal | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mixed type rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:mixed type rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mouse leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:mouse leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mucin-producing adenocarcinoma
n1=en:lelomyosarcoma | n2=en:mucin-producing adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:mucosal lentiginous melanoma
n1=en:lelomyosarcoma | n2=en:mucosal lentiginous melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:muscle cell
n1=en:lelomyosarcoma | n2=en:muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:muscle tissue
n1=en:lelomyosarcoma | n2=en:muscle tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:muscle tumor, special type
n1=en:lelomyosarcoma | n2=en:muscle tumor, special type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:muscle tumors (all subtypes)
n1=en:lelomyosarcoma | n2=en:muscle tumors (all subtypes) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myelodysplastic syndrome with isolated del(5q)
n1=en:lelomyosarcoma | n2=en:myelodysplastic syndrome with isolated del(5q) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myelodysplastic syndrome, no icd-o subtype
n1=en:lelomyosarcoma | n2=en:myelodysplastic syndrome, no icd-o subtype | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myeloid sarcoma
n1=en:lelomyosarcoma | n2=en:myeloid sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myeloliposarcoma
n1=en:lelomyosarcoma | n2=en:myeloliposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myeloproliferative neoplasm
n1=en:lelomyosarcoma | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myofibroma
n1=en:lelomyosarcoma | n2=en:myofibroma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myomatous neoplasm
n1=en:lelomyosarcoma | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myosarcoma
n1=en:lelomyosarcoma | n2=en:myosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxofibrosarcoma
n1=en:lelomyosarcoma | n2=en:myxofibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxoid chondrosarcoma
n1=en:lelomyosarcoma | n2=en:myxoid chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxoid leiomyoma
n1=en:lelomyosarcoma | n2=en:myxoid leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxoid leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:myxoid leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxoid liposarcoma
n1=en:lelomyosarcoma | n2=en:myxoid liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:myxosarcoma
n1=en:lelomyosarcoma | n2=en:myxosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nci ctep sdc non-rhabdomyosarcoma soft tissue sarcoma sub-category terminology
n1=en:lelomyosarcoma | n2=en:nci ctep sdc non-rhabdomyosarcoma soft tissue sarcoma sub-category terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nci ctep simplified disease classification terminology
n1=en:lelomyosarcoma | n2=en:nci ctep simplified disease classification terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ncit neoplasm core terminology
n1=en:lelomyosarcoma | n2=en:ncit neoplasm core terminology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:neoplasms, muscle tissue
n1=en:lelomyosarcoma | n2=en:neoplasms, muscle tissue | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:neoplastic connective and soft tissue cell
n1=en:lelomyosarcoma | n2=en:neoplastic connective and soft tissue cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:neoplastic muscle cell
n1=en:lelomyosarcoma | n2=en:neoplastic muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:neoplastic smooth muscle cell
n1=en:lelomyosarcoma | n2=en:neoplastic smooth muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:neuroblastoma
n1=en:lelomyosarcoma | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nodular melanoma
n1=en:lelomyosarcoma | n2=en:nodular melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:non-hodgkin lymphoma
n1=en:lelomyosarcoma | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:non-keratinizing sinonasal squamous cell carcinoma
n1=en:lelomyosarcoma | n2=en:non-keratinizing sinonasal squamous cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:non-small cell carcinoma
n1=en:lelomyosarcoma | n2=en:non-small cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nonseminomatous germ cell tumor
n1=en:lelomyosarcoma | n2=en:nonseminomatous germ cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nursing therapy
n1=en:lelomyosarcoma | n2=en:nursing therapy | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:nutritional management
n1=en:lelomyosarcoma | n2=en:nutritional management | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:olfactory neurogenic tumor
n1=en:lelomyosarcoma | n2=en:olfactory neurogenic tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:oligodendroglioma
n1=en:lelomyosarcoma | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:oral cavity leiomyoma
n1=en:lelomyosarcoma | n2=en:oral cavity leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:osteosarcoma
n1=en:lelomyosarcoma | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ovarian dermoid cyst with leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:ovarian dermoid cyst with leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:overlapping malignant neoplasm of gastrointestinal tract
n1=en:lelomyosarcoma | n2=en:overlapping malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:overlapping malignant neoplasm of ill-defined site
n1=en:lelomyosarcoma | n2=en:overlapping malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:overlapping malignant neoplasm of lip, oral cavity and pharynx
n1=en:lelomyosarcoma | n2=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:oxyphilic adenocarcinoma
n1=en:lelomyosarcoma | n2=en:oxyphilic adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:paget's disease and infiltrating duct carcinoma of breast
n1=en:lelomyosarcoma | n2=en:paget's disease and infiltrating duct carcinoma of breast | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pancreatoblastoma
n1=en:lelomyosarcoma | n2=en:pancreatoblastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:papillary meningioma
n1=en:lelomyosarcoma | n2=en:papillary meningioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:parasitic fibroid
n1=en:lelomyosarcoma | n2=en:parasitic fibroid | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:parasitology
n1=en:lelomyosarcoma | n2=en:parasitology | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:parosteal osteosarcoma
n1=en:lelomyosarcoma | n2=en:parosteal osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pathological aspects
n1=en:lelomyosarcoma | n2=en:pathological aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pericardial leiomyoma
n1=en:lelomyosarcoma | n2=en:pericardial leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:periosteal chondrosarcoma
n1=en:lelomyosarcoma | n2=en:periosteal chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:periosteal fibrosarcoma
n1=en:lelomyosarcoma | n2=en:periosteal fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:periosteal osteosarcoma
n1=en:lelomyosarcoma | n2=en:periosteal osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:peripheral primitive neuroectodermal tumor
n1=en:lelomyosarcoma | n2=en:peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:peripheral primitive neuroectodermal tumor of bone
n1=en:lelomyosarcoma | n2=en:peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:peripheral primitive neuroectodermal tumor of soft tissues
n1=en:lelomyosarcoma | n2=en:peripheral primitive neuroectodermal tumor of soft tissues | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pharmacotherapeutic
n1=en:lelomyosarcoma | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:phyllodes tumor
n1=en:lelomyosarcoma | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:physiopathological
n1=en:lelomyosarcoma | n2=en:physiopathological | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pilomatrical carcinoma
n1=en:lelomyosarcoma | n2=en:pilomatrical carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:plasma cell myeloma/plasmacytoma
n1=en:lelomyosarcoma | n2=en:plasma cell myeloma/plasmacytoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pleomorphic liposarcoma
n1=en:lelomyosarcoma | n2=en:pleomorphic liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pleomorphic rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:pleuropulmonary blastoma
n1=en:lelomyosarcoma | n2=en:pleuropulmonary blastoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:polycythemia vera
n1=en:lelomyosarcoma | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:polymorphous low grade adenocarcinoma
n1=en:lelomyosarcoma | n2=en:polymorphous low grade adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:poorly differentiated carcinoma
n1=en:lelomyosarcoma | n2=en:poorly differentiated carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma
n1=en:lelomyosarcoma | n2=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary broad ligament fibroid
n1=en:lelomyosarcoma | n2=en:primary broad ligament fibroid | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:primary leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant adenomatous neoplasm
n1=en:lelomyosarcoma | n2=en:primary malignant adenomatous neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of back
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of back | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of bone
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of ear, nose and/or throat
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of ear, nose and/or throat | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of endocrine gland
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of endocrine gland | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of gastrointestinal tract
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of head
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of head | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of independent multiple sites
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of independent multiple sites | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of muscle
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of muscle | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of neck
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of neck | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of nervous system
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of nervous system | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of respiratory tract
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of respiratory tract | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of sweat gland
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of sweat gland | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of trunk
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of trunk | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of unknown site
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of unknown site | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary malignant neoplasm of upper limb (disorder)
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of upper limb (disorder) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary myelofibrosis
n1=en:lelomyosarcoma | n2=en:primary myelofibrosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primary undifferentiated large cell carcinoma
n1=en:lelomyosarcoma | n2=en:primary undifferentiated large cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:primitive neuroectodermal tumor
n1=en:lelomyosarcoma | n2=en:primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:prolymphocytic lymphosarcoma
n1=en:lelomyosarcoma | n2=en:prolymphocytic lymphosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:prostate leiomyoma
n1=en:lelomyosarcoma | n2=en:prostate leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:psychology qualifier
n1=en:lelomyosarcoma | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:radiation-related sarcoma
n1=en:lelomyosarcoma | n2=en:radiation-related sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:radiotherapeutic
n1=en:lelomyosarcoma | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:rb1 gene
n1=en:lelomyosarcoma | n2=en:rb1 gene | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:rb1 wt allele
n1=en:lelomyosarcoma | n2=en:rb1 wt allele | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:reactive immunoproliferative disease
n1=en:lelomyosarcoma | n2=en:reactive immunoproliferative disease | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent alveolar soft part sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent alveolar soft part sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent chondrosarcoma
n1=en:lelomyosarcoma | n2=en:recurrent chondrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent ewing sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent extraskeletal ewing sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent extraskeletal osteosarcoma
n1=en:lelomyosarcoma | n2=en:recurrent extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:recurrent leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent liposarcoma
n1=en:lelomyosarcoma | n2=en:recurrent liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent malignant mesothelioma
n1=en:lelomyosarcoma | n2=en:recurrent malignant mesothelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent osteosarcoma
n1=en:lelomyosarcoma | n2=en:recurrent osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:recurrent rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:recurrent synovial sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent synovial sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:refractory anemia
n1=en:lelomyosarcoma | n2=en:refractory anemia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:refractory anemia with excess blasts in transformation
n1=en:lelomyosarcoma | n2=en:refractory anemia with excess blasts in transformation | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:refractory anemia with ring sideroblasts
n1=en:lelomyosarcoma | n2=en:refractory anemia with ring sideroblasts | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:refractory cytopenia with multilineage dysplasia
n1=en:lelomyosarcoma | n2=en:refractory cytopenia with multilineage dysplasia | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:refractory cytopenia with multilineage dysplasia and ring sideroblasts
n1=en:lelomyosarcoma | n2=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:regressed germ cell tumor
n1=en:lelomyosarcoma | n2=en:regressed germ cell tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:regressing melanoma
n1=en:lelomyosarcoma | n2=en:regressing melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:rehabilitation aspects
n1=en:lelomyosarcoma | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:retroperitoneal sarcoma
n1=en:lelomyosarcoma | n2=en:retroperitoneal sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:rhabdoid tumor
n1=en:lelomyosarcoma | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:roentgenographic
n1=en:lelomyosarcoma | n2=en:roentgenographic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:round cell liposarcoma
n1=en:lelomyosarcoma | n2=en:round cell liposarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:round ligament fibroid
n1=en:lelomyosarcoma | n2=en:round ligament fibroid | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma
n1=en:lelomyosarcoma | n2=en:sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma by ajcc grade
n1=en:lelomyosarcoma | n2=en:sarcoma by ajcc grade | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma by fnclcc grade
n1=en:lelomyosarcoma | n2=en:sarcoma by fnclcc grade | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma by nci grade
n1=en:lelomyosarcoma | n2=en:sarcoma by nci grade | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma of back
n1=en:lelomyosarcoma | n2=en:sarcoma of back | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma of pelvis
n1=en:lelomyosarcoma | n2=en:sarcoma of pelvis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma of posterior mediastinum
n1=en:lelomyosarcoma | n2=en:sarcoma of posterior mediastinum | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma, experimental
n1=en:lelomyosarcoma | n2=en:sarcoma, experimental | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcoma, metastatic
n1=en:lelomyosarcoma | n2=en:sarcoma, metastatic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcomatoid carcinoma
n1=en:lelomyosarcoma | n2=en:sarcomatoid carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcomatoid mesothelioma
n1=en:lelomyosarcoma | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcomatoid squamous cell carcinoma
n1=en:lelomyosarcoma | n2=en:sarcomatoid squamous cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcomatoid transitional cell carcinoma
n1=en:lelomyosarcoma | n2=en:sarcomatoid transitional cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sarcomatosis
n1=en:lelomyosarcoma | n2=en:sarcomatosis | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:second primary malignant neoplasm
n1=en:lelomyosarcoma | n2=en:second primary malignant neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:secondary malignant neoplasm of soft tissues
n1=en:lelomyosarcoma | n2=en:secondary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:secondary osteosarcoma
n1=en:lelomyosarcoma | n2=en:secondary osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:seromucinous carcinoma
n1=en:lelomyosarcoma | n2=en:seromucinous carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sertoli cell carcinoma
n1=en:lelomyosarcoma | n2=en:sertoli cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sertoli-leydig cell tumor, poorly differentiated
n1=en:lelomyosarcoma | n2=en:sertoli-leydig cell tumor, poorly differentiated | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:signet ring cell carcinoma
n1=en:lelomyosarcoma | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skeletal muscle neoplasm
n1=en:lelomyosarcoma | n2=en:skeletal muscle neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin adenoid basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin adenoid basal cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin basosquamous cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin basosquamous cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin fibroepithelial basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin fibroepithelial basal cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin infiltrating basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin infiltrating basal cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin metatypical carcinoma
n1=en:lelomyosarcoma | n2=en:skin metatypical carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:skin nodular basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin nodular basal cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small cell carcinoma
n1=en:lelomyosarcoma | n2=en:small cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small cell carcinoma, fusiform cell type
n1=en:lelomyosarcoma | n2=en:small cell carcinoma, fusiform cell type | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small cell osteosarcoma
n1=en:lelomyosarcoma | n2=en:small cell osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small cell sarcoma
n1=en:lelomyosarcoma | n2=en:small cell sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small intestinal leiomyoma
n1=en:lelomyosarcoma | n2=en:small intestinal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:small intestinal leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:small intestinal leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:smooth muscle cell
n1=en:lelomyosarcoma | n2=en:smooth muscle cell | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:smooth muscle neoplasm
n1=en:lelomyosarcoma | n2=en:smooth muscle neoplasm | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:smooth muscle tumor of uncertain malignant potential
n1=en:lelomyosarcoma | n2=en:smooth muscle tumor of uncertain malignant potential | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:soft tissue neoplasms malignant and unspecified
n1=en:lelomyosarcoma | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas)
n1=en:lelomyosarcoma | n2=en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:soft tissue sarcoma
n1=en:lelomyosarcoma | n2=en:soft tissue sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:soft tissue sarcomas histology unspecified
n1=en:lelomyosarcoma | n2=en:soft tissue sarcomas histology unspecified | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:solid papillary carcinoma with invasion
n1=en:lelomyosarcoma | n2=en:solid papillary carcinoma with invasion | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:solid pseudopapillary carcinoma
n1=en:lelomyosarcoma | n2=en:solid pseudopapillary carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:spindle cell rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:spindle cell rhabdomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:spindle cell sarcoma
n1=en:lelomyosarcoma | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:spiradenocarcinoma
n1=en:lelomyosarcoma | n2=en:spiradenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:steroid cell tumor, malignant
n1=en:lelomyosarcoma | n2=en:steroid cell tumor, malignant | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:storiform-pleomorphic malignant fibrous histiocytoma
n1=en:lelomyosarcoma | n2=en:storiform-pleomorphic malignant fibrous histiocytoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:stromal sarcoma
n1=en:lelomyosarcoma | n2=en:stromal sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:superficial multifocal basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:superficial multifocal basal cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:superficial spreading melanoma
n1=en:lelomyosarcoma | n2=en:superficial spreading melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:surgical aspects
n1=en:lelomyosarcoma | n2=en:surgical aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:sweat gland adenocarcinoma
n1=en:lelomyosarcoma | n2=en:sweat gland adenocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:synovial sarcoma
n1=en:lelomyosarcoma | n2=en:synovial sarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:synovial sarcoma - category
n1=en:lelomyosarcoma | n2=en:synovial sarcoma - category | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:taxonomic
n1=en:lelomyosarcoma | n2=en:taxonomic | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:telangiectatic osteosarcoma
n1=en:lelomyosarcoma | n2=en:telangiectatic osteosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:teratoid medulloepithelioma
n1=en:lelomyosarcoma | n2=en:teratoid medulloepithelioma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:testicular spermatocytic seminoma
n1=en:lelomyosarcoma | n2=en:testicular spermatocytic seminoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:therapeutic aspects
n1=en:lelomyosarcoma | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:therapy-related myelodysplastic syndrome
n1=en:lelomyosarcoma | n2=en:therapy-related myelodysplastic syndrome | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:thymic carcinoma
n1=en:lelomyosarcoma | n2=en:thymic carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:thymoma type b3
n1=en:lelomyosarcoma | n2=en:thymoma type b3 | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:thyroid gland carcinoma showing thymus-like differentiation
n1=en:lelomyosarcoma | n2=en:thyroid gland carcinoma showing thymus-like differentiation | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:thyroid gland spindle cell tumor with thymus-like differentiation
n1=en:lelomyosarcoma | n2=en:thyroid gland spindle cell tumor with thymus-like differentiation | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:tracheal leiomyoma
n1=en:lelomyosarcoma | n2=en:tracheal leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:transitional cell carcinoma
n1=en:lelomyosarcoma | n2=en:transitional cell carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:trichilemmocarcinoma
n1=en:lelomyosarcoma | n2=en:trichilemmocarcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:type a spindle cell melanoma
n1=en:lelomyosarcoma | n2=en:type a spindle cell melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:type b spindle cell melanoma
n1=en:lelomyosarcoma | n2=en:type b spindle cell melanoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ultrastructure
n1=en:lelomyosarcoma | n2=en:ultrastructure | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:undifferentiated carcinoma
n1=en:lelomyosarcoma | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:undifferentiated high grade pleomorphic sarcoma of bone
n1=en:lelomyosarcoma | n2=en:undifferentiated high grade pleomorphic sarcoma of bone | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells
n1=en:lelomyosarcoma | n2=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:undifferentiated sarcoma, not otherwise specified
n1=en:lelomyosarcoma | n2=en:undifferentiated sarcoma, not otherwise specified | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:ureter leiomyoma
n1=en:lelomyosarcoma | n2=en:ureter leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:urethral leiomyoma
n1=en:lelomyosarcoma | n2=en:urethral leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:use of ultrasonography
n1=en:lelomyosarcoma | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:uterine corpus leiomyoma
n1=en:lelomyosarcoma | n2=en:uterine corpus leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:uterine corpus leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:uterine corpus leiomyosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:vaccine-induced fibrosarcoma
n1=en:lelomyosarcoma | n2=en:vaccine-induced fibrosarcoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:verrucous carcinoma
n1=en:lelomyosarcoma | n2=en:verrucous carcinoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:veterinary aspects
n1=en:lelomyosarcoma | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:viruses
n1=en:lelomyosarcoma | n2=en:viruses | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
en:vulvar leiomyoma
n1=en:lelomyosarcoma | n2=en:vulvar leiomyoma | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
leiomyosarcome
n1=en:lelomyosarcoma | n2=leiomyosarcome | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
léiomyosarcome cutané
n1=en:lelomyosarcoma | n2=léiomyosarcome cutané | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
léiomyosarcomes
n1=en:lelomyosarcoma | n2=léiomyosarcomes | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
maladie
n1=en:lelomyosarcoma | n2=maladie | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
maladies
n1=en:lelomyosarcoma | n2=maladies | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
médecine
n1=en:lelomyosarcoma | n2=médecine | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
Médecine
n1=en:lelomyosarcoma | n2=Médecine | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
médecine spécialisée
n1=en:lelomyosarcoma | n2=médecine spécialisée | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
médecine
(science)
n1=en:lelomyosarcoma | n2=médecine (science) | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
muscle
n1=en:lelomyosarcoma | n2=muscle | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
oncologie
n1=en:lelomyosarcoma | n2=oncologie | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
processus pathologique
n1=en:lelomyosarcoma | n2=processus pathologique | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
spécialités médicales
n1=en:lelomyosarcoma | n2=spécialités médicales | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
tissu conjonctif
n1=en:lelomyosarcoma | n2=tissu conjonctif | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
tumeur
n1=en:lelomyosarcoma | n2=tumeur | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
tumeur maligne
n1=en:lelomyosarcoma | n2=tumeur maligne | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
tumeur mésenchymateuse maligne
n1=en:lelomyosarcoma | n2=tumeur mésenchymateuse maligne | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 45 / 0.957 ->
tumeurs
n1=en:lelomyosarcoma | n2=tumeurs | rel=r_associated | relid=0 | w=45
- en:lelomyosarcoma --
r_associated #0: 41 / 0.872 ->
léiomyosarcome, sai
n1=en:lelomyosarcoma | n2=léiomyosarcome, sai | rel=r_associated | relid=0 | w=41
- en:lelomyosarcoma --
r_associated #0: 40 / 0.851 ->
en:leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma | rel=r_associated | relid=0 | w=40
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:adult rhabdomyoma
n1=en:lelomyosarcoma | n2=en:adult rhabdomyoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:atypical teratoid/rhabdoid tumor
n1=en:lelomyosarcoma | n2=en:atypical teratoid/rhabdoid tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:avian leukosis/sarcoma
n1=en:lelomyosarcoma | n2=en:avian leukosis/sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:breast sarcoma
n1=en:lelomyosarcoma | n2=en:breast sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:carcinoma ex pleomorphic adenoma
n1=en:lelomyosarcoma | n2=en:carcinoma ex pleomorphic adenoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements
n1=en:lelomyosarcoma | n2=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:cellular leiomyoma
n1=en:lelomyosarcoma | n2=en:cellular leiomyoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:chemically induced
n1=en:lelomyosarcoma | n2=en:chemically induced | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:desmoplastic melanoma
n1=en:lelomyosarcoma | n2=en:desmoplastic melanoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:diagnosis aspect
n1=en:lelomyosarcoma | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:digital papillary eccrine carcinoma
n1=en:lelomyosarcoma | n2=en:digital papillary eccrine carcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:dysgerminoma
n1=en:lelomyosarcoma | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:enzymology
n1=en:lelomyosarcoma | n2=en:enzymology | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:esophageal leiomyoma
n1=en:lelomyosarcoma | n2=en:esophageal leiomyoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:esthesioneurocytoma
n1=en:lelomyosarcoma | n2=en:esthesioneurocytoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:ethnologic
n1=en:lelomyosarcoma | n2=en:ethnologic | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:extraskeletal chondrosarcoma metastatic
n1=en:lelomyosarcoma | n2=en:extraskeletal chondrosarcoma metastatic | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:extraskeletal osteosarcoma
n1=en:lelomyosarcoma | n2=en:extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:follicular dendritic sarcoma of intraabdominal lymph node
n1=en:lelomyosarcoma | n2=en:follicular dendritic sarcoma of intraabdominal lymph node | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:high risk gastrointestinal stromal tumor
n1=en:lelomyosarcoma | n2=en:high risk gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:indolent clinical course
n1=en:lelomyosarcoma | n2=en:indolent clinical course | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:interdigitating dendritic cell sarcoma
n1=en:lelomyosarcoma | n2=en:interdigitating dendritic cell sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:kaposi sarcoma
n1=en:lelomyosarcoma | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:langerhans cell sarcoma
n1=en:lelomyosarcoma | n2=en:langerhans cell sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:leiomyomatosis
n1=en:lelomyosarcoma | n2=en:leiomyomatosis | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:leiomyosarcoma of the mouse nervous system
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma of the mouse nervous system | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:liposarcoma
n1=en:lelomyosarcoma | n2=en:liposarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant bone marrow neoplasm
n1=en:lelomyosarcoma | n2=en:malignant bone marrow neoplasm | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant glioma
n1=en:lelomyosarcoma | n2=en:malignant glioma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant mixed tumor, chondrosarcomatous type
n1=en:lelomyosarcoma | n2=en:malignant mixed tumor, chondrosarcomatous type | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant neoplasm musculoskeletal
n1=en:lelomyosarcoma | n2=en:malignant neoplasm musculoskeletal | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant neuroendocrine neoplasm, epithelial
n1=en:lelomyosarcoma | n2=en:malignant neuroendocrine neoplasm, epithelial | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant neuroendocrine tumor
n1=en:lelomyosarcoma | n2=en:malignant neuroendocrine tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant phyllodes tumor
n1=en:lelomyosarcoma | n2=en:malignant phyllodes tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:malignant thymoma
n1=en:lelomyosarcoma | n2=en:malignant thymoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:metastases to muscle
n1=en:lelomyosarcoma | n2=en:metastases to muscle | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:metastasizing leiomyoma
n1=en:lelomyosarcoma | n2=en:metastasizing leiomyoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:mixed germ cell tumor
n1=en:lelomyosarcoma | n2=en:mixed germ cell tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:mixed mesodermal (mullerian) tumor
n1=en:lelomyosarcoma | n2=en:mixed mesodermal (mullerian) tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:mucoepidermoid carcinoma
n1=en:lelomyosarcoma | n2=en:mucoepidermoid carcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:myogenic sarcoma, nos
n1=en:lelomyosarcoma | n2=en:myogenic sarcoma, nos | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:myolipoma
n1=en:lelomyosarcoma | n2=en:myolipoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:neuroepithelioma
n1=en:lelomyosarcoma | n2=en:neuroepithelioma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:overlapping malignant melanoma of skin
n1=en:lelomyosarcoma | n2=en:overlapping malignant melanoma of skin | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:pancreatic acinar cell cystadenocarcinoma
n1=en:lelomyosarcoma | n2=en:pancreatic acinar cell cystadenocarcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:papillary transitional cell carcinoma
n1=en:lelomyosarcoma | n2=en:papillary transitional cell carcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:poorly differentiated sarcoma
n1=en:lelomyosarcoma | n2=en:poorly differentiated sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:primary malignant neoplasm of articular cartilage
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of articular cartilage | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:primary malignant neoplasm of ill-defined site
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:primary malignant neoplasm of paraganglion
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of paraganglion | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:primary malignant neoplasm of soft tissues
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:recurrent malignant peripheral nerve sheath tumor
n1=en:lelomyosarcoma | n2=en:recurrent malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:recurrent peripheral primitive neuroectodermal tumor of bone
n1=en:lelomyosarcoma | n2=en:recurrent peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:refractory anemia with excess blasts
n1=en:lelomyosarcoma | n2=en:refractory anemia with excess blasts | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:rhabdomyomatous neoplasm - category
n1=en:lelomyosarcoma | n2=en:rhabdomyomatous neoplasm - category | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:sarcoma of head and neck
n1=en:lelomyosarcoma | n2=en:sarcoma of head and neck | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements
n1=en:lelomyosarcoma | n2=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:skin basal cell carcinoma
n1=en:lelomyosarcoma | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:spindle cell melanoma
n1=en:lelomyosarcoma | n2=en:spindle cell melanoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:t lymphoblastic leukemia/lymphoma
n1=en:lelomyosarcoma | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:testicular leiomyosarcoma
n1=en:lelomyosarcoma | n2=en:testicular leiomyosarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:thyroid gland diffuse sclerosing papillary carcinoma
n1=en:lelomyosarcoma | n2=en:thyroid gland diffuse sclerosing papillary carcinoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:undifferentiated pleomorphic sarcoma, inflammatory variant
n1=en:lelomyosarcoma | n2=en:undifferentiated pleomorphic sarcoma, inflammatory variant | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:vaginal leiomyoma
n1=en:lelomyosarcoma | n2=en:vaginal leiomyoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
en:vulvar sarcoma
n1=en:lelomyosarcoma | n2=en:vulvar sarcoma | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
léiomyosarcome myxoïde
n1=en:lelomyosarcoma | n2=léiomyosarcome myxoïde | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 35 / 0.745 ->
tumeur du tissu musculaire
n1=en:lelomyosarcoma | n2=tumeur du tissu musculaire | rel=r_associated | relid=0 | w=35
- en:lelomyosarcoma --
r_associated #0: 34 / 0.723 ->
léiomyosarcome
n1=en:lelomyosarcoma | n2=léiomyosarcome | rel=r_associated | relid=0 | w=34
- en:lelomyosarcoma --
r_associated #0: 33 / 0.702 ->
maladie grave
n1=en:lelomyosarcoma | n2=maladie grave | rel=r_associated | relid=0 | w=33
- en:lelomyosarcoma --
r_associated #0: 33 / 0.702 ->
poumon
n1=en:lelomyosarcoma | n2=poumon | rel=r_associated | relid=0 | w=33
- en:lelomyosarcoma --
r_associated #0: 32 / 0.681 ->
Leiner-Moussous (syndrome de)
n1=en:lelomyosarcoma | n2=Leiner-Moussous (syndrome de) | rel=r_associated | relid=0 | w=32
- en:lelomyosarcoma --
r_associated #0: 32 / 0.681 ->
muscle lisse
n1=en:lelomyosarcoma | n2=muscle lisse | rel=r_associated | relid=0 | w=32
- en:lelomyosarcoma --
r_associated #0: 32 / 0.681 ->
pathologie
n1=en:lelomyosarcoma | n2=pathologie | rel=r_associated | relid=0 | w=32
- en:lelomyosarcoma --
r_associated #0: 32 / 0.681 ->
utérus
n1=en:lelomyosarcoma | n2=utérus | rel=r_associated | relid=0 | w=32
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:adult pleomorphic rhabdomyosarcoma
n1=en:lelomyosarcoma | n2=en:adult pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:aspects of mortality statistics
n1=en:lelomyosarcoma | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:biphasic mesothelioma
n1=en:lelomyosarcoma | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:bizarre leiomyoma
n1=en:lelomyosarcoma | n2=en:bizarre leiomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:breast leiomyoma
n1=en:lelomyosarcoma | n2=en:breast leiomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:carcinoma in situ of sphincter of oddi
n1=en:lelomyosarcoma | n2=en:carcinoma in situ of sphincter of oddi | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:chief cell adenocarcinoma
n1=en:lelomyosarcoma | n2=en:chief cell adenocarcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:ciliary body leiomyoma
n1=en:lelomyosarcoma | n2=en:ciliary body leiomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:clear cell sarcoma of soft tissue
n1=en:lelomyosarcoma | n2=en:clear cell sarcoma of soft tissue | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:epidemiologic
n1=en:lelomyosarcoma | n2=en:epidemiologic | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:fibrosarcoma of connective tissue
n1=en:lelomyosarcoma | n2=en:fibrosarcoma of connective tissue | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:fibrosarcoma of spleen
n1=en:lelomyosarcoma | n2=en:fibrosarcoma of spleen | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:gain of chromosome 20
n1=en:lelomyosarcoma | n2=en:gain of chromosome 20 | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:gallbladder leiomyoma
n1=en:lelomyosarcoma | n2=en:gallbladder leiomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:large cell carcinoma
n1=en:lelomyosarcoma | n2=en:large cell carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:leiomyosarcoma (excluding uterine leiomyosarcoma)
n1=en:lelomyosarcoma | n2=en:leiomyosarcoma (excluding uterine leiomyosarcoma) | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:lobular breast carcinoma
n1=en:lelomyosarcoma | n2=en:lobular breast carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:low grade myofibroblastic sarcoma
n1=en:lelomyosarcoma | n2=en:low grade myofibroblastic sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:lymphangiosarcoma
n1=en:lelomyosarcoma | n2=en:lymphangiosarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:lymphoma
n1=en:lelomyosarcoma | n2=en:lymphoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant aortic body tumor
n1=en:lelomyosarcoma | n2=en:malignant aortic body tumor | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant blood vessel neoplasm
n1=en:lelomyosarcoma | n2=en:malignant blood vessel neoplasm | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant bone neoplasm
n1=en:lelomyosarcoma | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant epithelioma
n1=en:lelomyosarcoma | n2=en:malignant epithelioma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant glomus tumor
n1=en:lelomyosarcoma | n2=en:malignant glomus tumor | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant granulosa cell tumor
n1=en:lelomyosarcoma | n2=en:malignant granulosa cell tumor | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant histiocytosis
n1=en:lelomyosarcoma | n2=en:malignant histiocytosis | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant mesothelioma
n1=en:lelomyosarcoma | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant myomatous tumor
n1=en:lelomyosarcoma | n2=en:malignant myomatous tumor | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant peripheral nerve sheath tumor with perineurial differentiation
n1=en:lelomyosarcoma | n2=en:malignant peripheral nerve sheath tumor with perineurial differentiation | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:malignant sertoli cell tumor
n1=en:lelomyosarcoma | n2=en:malignant sertoli cell tumor | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:mediastinal leiomyoma
n1=en:lelomyosarcoma | n2=en:mediastinal leiomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:metastases to perineum
n1=en:lelomyosarcoma | n2=en:metastases to perineum | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:neoplasm of uncertain behavior of muscle
n1=en:lelomyosarcoma | n2=en:neoplasm of uncertain behavior of muscle | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:neoplastic cell
n1=en:lelomyosarcoma | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:neuron, neuroepithelial cell, and supporting cell of the nervous system
n1=en:lelomyosarcoma | n2=en:neuron, neuroepithelial cell, and supporting cell of the nervous system | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:paget disease and intraductal carcinoma of the breast
n1=en:lelomyosarcoma | n2=en:paget disease and intraductal carcinoma of the breast | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:polyembryoma
n1=en:lelomyosarcoma | n2=en:polyembryoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:polygonal cell carcinoma
n1=en:lelomyosarcoma | n2=en:polygonal cell carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:primary malignant neoplasm of lower limb
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:primary malignant neoplasm of unspecified site (clinical)
n1=en:lelomyosarcoma | n2=en:primary malignant neoplasm of unspecified site (clinical) | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:pseudoglandular squamous cell carcinoma
n1=en:lelomyosarcoma | n2=en:pseudoglandular squamous cell carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:recurrent epithelioid sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent epithelioid sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:recurrent undifferentiated pleomorphic sarcoma
n1=en:lelomyosarcoma | n2=en:recurrent undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:rhabdomyoma
n1=en:lelomyosarcoma | n2=en:rhabdomyoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:secretory breast carcinoma
n1=en:lelomyosarcoma | n2=en:secretory breast carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:skin sarcoma
n1=en:lelomyosarcoma | n2=en:skin sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:small cell carcinoma carcinomatosis
n1=en:lelomyosarcoma | n2=en:small cell carcinoma carcinomatosis | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:small cell intermediate cell carcinoma
n1=en:lelomyosarcoma | n2=en:small cell intermediate cell carcinoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:smooth muscle tissue
n1=en:lelomyosarcoma | n2=en:smooth muscle tissue | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:spongioneuroblastoma
n1=en:lelomyosarcoma | n2=en:spongioneuroblastoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:undifferentiated (embryonal) sarcoma
n1=en:lelomyosarcoma | n2=en:undifferentiated (embryonal) sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:undifferentiated pleomorphic sarcoma
n1=en:lelomyosarcoma | n2=en:undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
en:well differentiated liposarcoma
n1=en:lelomyosarcoma | n2=en:well differentiated liposarcoma | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
fibre
n1=en:lelomyosarcoma | n2=fibre | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 30 / 0.638 ->
léiomyosarcome épithélioïde
n1=en:lelomyosarcoma | n2=léiomyosarcome épithélioïde | rel=r_associated | relid=0 | w=30
- en:lelomyosarcoma --
r_associated #0: 29 / 0.617 ->
cancer de l'intestin grêle
n1=en:lelomyosarcoma | n2=cancer de l'intestin grêle | rel=r_associated | relid=0 | w=29
- en:lelomyosarcoma --
r_associated #0: 28 / 0.596 ->
sarcome de la vessie
n1=en:lelomyosarcoma | n2=sarcome de la vessie | rel=r_associated | relid=0 | w=28
- en:lelomyosarcoma --
r_associated #0: 27 / 0.574 ->
sarcome musculaire
n1=en:lelomyosarcoma | n2=sarcome musculaire | rel=r_associated | relid=0 | w=27
- en:lelomyosarcoma --
r_associated #0: 26 / 0.553 ->
en:medicine
n1=en:lelomyosarcoma | n2=en:medicine | rel=r_associated | relid=0 | w=26
- en:lelomyosarcoma --
r_associated #0: 15 / 0.319 ->
en:oncology
n1=en:lelomyosarcoma | n2=en:oncology | rel=r_associated | relid=0 | w=15
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
cancer du foie
n1=en:lelomyosarcoma | n2=cancer du foie | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
cancer épithélial
n1=en:lelomyosarcoma | n2=cancer épithélial | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
carcinoma
n1=en:lelomyosarcoma | n2=carcinoma | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:bladder sarcoma
n1=en:lelomyosarcoma | n2=en:bladder sarcoma | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:epithelial carcinoma
n1=en:lelomyosarcoma | n2=en:epithelial carcinoma | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:epulides
n1=en:lelomyosarcoma | n2=en:epulides | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:hematocele
n1=en:lelomyosarcoma | n2=en:hematocele | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:mastadenoma
n1=en:lelomyosarcoma | n2=en:mastadenoma | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:muscular sarcoma
n1=en:lelomyosarcoma | n2=en:muscular sarcoma | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:small intestine cancer
n1=en:lelomyosarcoma | n2=en:small intestine cancer | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:tumoral
n1=en:lelomyosarcoma | n2=en:tumoral | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
en:tumoural
n1=en:lelomyosarcoma | n2=en:tumoural | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
épulis
n1=en:lelomyosarcoma | n2=épulis | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
hématocèle
n1=en:lelomyosarcoma | n2=hématocèle | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
inondation endiguée de Vigne
n1=en:lelomyosarcoma | n2=inondation endiguée de Vigne | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
léiomyosarcome épithélioïde.
n1=en:lelomyosarcoma | n2=léiomyosarcome épithélioïde. | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
loupe
n1=en:lelomyosarcoma | n2=loupe | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
maladie néoplasique
n1=en:lelomyosarcoma | n2=maladie néoplasique | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
myoblastome
n1=en:lelomyosarcoma | n2=myoblastome | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
nouvelle pousse
n1=en:lelomyosarcoma | n2=nouvelle pousse | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
syndrome néoplasique
n1=en:lelomyosarcoma | n2=syndrome néoplasique | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumeur cancéreuse
n1=en:lelomyosarcoma | n2=tumeur cancéreuse | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumeur du sein
n1=en:lelomyosarcoma | n2=tumeur du sein | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumeur maligne secondaire du foie
n1=en:lelomyosarcoma | n2=tumeur maligne secondaire du foie | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumor
n1=en:lelomyosarcoma | n2=tumor | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumoral
n1=en:lelomyosarcoma | n2=tumoral | rel=r_associated | relid=0 | w=5
- en:lelomyosarcoma --
r_associated #0: 5 / 0.106 ->
tumorale
n1=en:lelomyosarcoma | n2=tumorale | rel=r_associated | relid=0 | w=5
| ≈ 768 relations entrantes
- léiomyosarcome ---
r_associated #0: 69 -->
en:lelomyosarcoma
n1=léiomyosarcome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=69
- en:leiomyosarcoma ---
r_associated #0: 67 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=67
- leiomyosarcome ---
r_associated #0: 59 -->
en:lelomyosarcoma
n1=leiomyosarcome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=59
- léiomyosarcomes ---
r_associated #0: 35 -->
en:lelomyosarcoma
n1=léiomyosarcomes | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=35
- léiomyosarcome, sai ---
r_associated #0: 30 -->
en:lelomyosarcoma
n1=léiomyosarcome, sai | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=30
- Médecine ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=Médecine | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- arrhénoblastome malin ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=arrhénoblastome malin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- cancer ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=cancer | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- cancer osseux ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=cancer osseux | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- cancérologie ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=cancérologie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- carcinologie ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=carcinologie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- carcinologie
(oncologie) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=carcinologie (oncologie) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- cellule musculaire lisse ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=cellule musculaire lisse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- cellules musculaires lisses ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=cellules musculaires lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:acinar cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:acinar cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:acral lentiginous melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:acral lentiginous melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adamantinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adamantinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adenocarcinoma in adenomatous polyp ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adenocarcinoma in adenomatous polyp | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adenocarcinoma in villous adenoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adenocarcinoma in villous adenoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adenomyoepithelioma with carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adenomyoepithelioma with carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adenosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adenosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adenosquamous carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adenosquamous carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adnexal carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adnexal carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adult pleomorphic rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adult pleomorphic rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:adult rhabdomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:adult rhabdomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:alpha heavy chain disease ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:alpha heavy chain disease | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:alveolar rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:alveolar rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:alveolar soft part sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:alveolar soft part sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:amelanotic melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:amelanotic melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ameloblastic fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ameloblastic fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ameloblastic odontosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ameloblastic odontosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:anal canal cloacogenic carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:anal canal cloacogenic carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:anal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:anal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:anaplastic (malignant) meningioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:anaplastic (malignant) meningioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:anaplastic ganglioglioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:anaplastic ganglioglioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:angioleiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:angioleiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:angiomyoliposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:angiomyoliposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:angiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:angiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:angiosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:angiosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:appendix leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:appendix leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:askin tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:askin tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:aspects of mortality statistics ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:aspects of mortality statistics | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:aspects of radionuclide imaging ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:aspects of radionuclide imaging | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:atypical medullary carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:atypical medullary carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:atypical teratoid/rhabdoid tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:atypical teratoid/rhabdoid tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:avian leukosis/sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:avian leukosis/sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:balloon cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:balloon cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:basaloid carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:basaloid carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:benign muscle neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:benign muscle neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:benign myomatous tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:benign myomatous tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:biphasic mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:biphasic mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:bizarre leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:bizarre leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:bladder leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:bladder leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:blood supply aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:blood supply aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:bone leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:bone leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:bone sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:bone sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:breast leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:breast leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:breast sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:breast sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:burkitt leukemia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:burkitt leukemia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinofibroma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinofibroma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma ex pleomorphic adenoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma ex pleomorphic adenoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma in situ of sphincter of oddi ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma in situ of sphincter of oddi | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma of bone, connective tissue, skin and breast ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma of bone, connective tissue, skin and breast | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma of lip, oral cavity and pharynx ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma of lip, oral cavity and pharynx | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma with osteoclast-like giant cells ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma with osteoclast-like giant cells | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carcinosarcoma, embryonal ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carcinosarcoma, embryonal | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:carney triad ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:carney triad | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cdisc send terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cdisc send terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cdisc send tumor findings results terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cdisc send tumor findings results terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cellular leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cellular leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cellular secretion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cellular secretion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:central nervous system leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:central nervous system leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cervical leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cervical leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chemical aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chemical aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chemically induced ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chemically induced | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chief cell adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chief cell adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chondroblastic osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chondroblastic osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chondroblastoma, malignant ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chondroblastoma, malignant | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chondroid chordoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chondroid chordoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chordoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chordoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:choriocarcinoma combined with other germ cell elements ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:choriocarcinoma combined with other germ cell elements | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:choroidal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:choroidal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:chronic myelomonocytic leukemia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:chronic myelomonocytic leukemia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ciliary body leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ciliary body leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:classic kaposi sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:classic kaposi sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:clear cell chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:clear cell chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:clear cell sarcoma of soft tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:clear cell sarcoma of soft tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:clear cell sarcoma of the kidney ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:clear cell sarcoma of the kidney | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:clinical data interchange standards consortium terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:clinical data interchange standards consortium terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:colorectal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:colorectal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:combined small cell lung carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:combined small cell lung carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:complication aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:complication aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:composite hodgkin and non-hodgkin lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:composite hodgkin and non-hodgkin lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:congenital mesh qualifier ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:congenital mesh qualifier | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:connective and soft tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:connective and soft tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:connective and soft tissue cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:connective and soft tissue cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:conventional osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:conventional osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cutaneous leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cutaneous leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:cystic partially differentiated nephroblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:cystic partially differentiated nephroblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:dedifferentiated chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:dedifferentiated chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:dedifferentiated chordoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:dedifferentiated chordoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:dedifferentiated liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:dedifferentiated liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:deep leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:deep leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:del(13q12-13) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:del(13q12-13) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:del(13q32-qter) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:del(13q32-qter) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:del(3p21-23) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:del(3p21-23) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:del(8p21-pter) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:del(8p21-pter) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:dermatofibrosarcoma protuberans ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:dermatofibrosarcoma protuberans | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:desmoid-type fibromatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:desmoid-type fibromatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:desmoplastic melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:desmoplastic melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:desmoplastic mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:desmoplastic mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:desmoplastic small round cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:desmoplastic small round cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:diagnosis aspect ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:diagnosis aspect | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:diffuse embryoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:diffuse embryoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:digital papillary eccrine carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:digital papillary eccrine carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:duct carcinoma, desmoplastic type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:duct carcinoma, desmoplastic type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ductal carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ductal carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:dysgerminoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:dysgerminoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:eccrine adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:eccrine adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:eccrine porocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:eccrine porocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ectomesenchymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ectomesenchymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:embryologic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:embryologic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:embryonal rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:embryonal rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:embryonal tumor with multilayered rosettes, c19mc-altered ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:embryonal tumor with multilayered rosettes, c19mc-altered | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:encapsulated papillary carcinoma with invasion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:encapsulated papillary carcinoma with invasion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:endometrial stromal sarcoma - category ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:endometrial stromal sarcoma - category | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:endometrial stromal tumors ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:endometrial stromal tumors | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:enzymology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:enzymology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epidemiologic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epidemiologic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelial cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelial cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelial tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelial tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelial-myoepithelial carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelial-myoepithelial carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid cell type gastrointestinal stromal tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid cell type gastrointestinal stromal tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid malignant peripheral nerve sheath tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid malignant peripheral nerve sheath tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:epithelioid trophoblastic tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:epithelioid trophoblastic tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:esophageal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:esophageal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:essential thrombocythemia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:essential thrombocythemia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:esthesioneurocytoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:esthesioneurocytoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ethnologic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ethnologic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:etiology aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:etiology aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ewing sarcoma/peripheral primitive neuroectodermal tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:exposure as collected domain ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:exposure as collected domain | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extrahepatic bile duct leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extrahepatic bile duct leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extramammary paget disease ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extramammary paget disease | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extrarenal rhabdoid tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extrarenal rhabdoid tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extraskeletal chondrosarcoma metastatic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extraskeletal chondrosarcoma metastatic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extraskeletal chondrosarcoma recurrent ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extraskeletal chondrosarcoma recurrent | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extraskeletal ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extraskeletal ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extraskeletal myxoid chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extraskeletal myxoid chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:extraskeletal osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:extraskeletal osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fallopian tube leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fallopian tube leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:familial letterer-siwe disease ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:familial letterer-siwe disease | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fascial fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fascial fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fetal rhabdomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fetal rhabdomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibroblastic liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibroblastic liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibroblastic osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibroblastic osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibroma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibroma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibrosarcoma of connective tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibrosarcoma of connective tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:fibrosarcoma of spleen ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:fibrosarcoma of spleen | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:follicular dendritic cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:follicular dendritic cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:follicular dendritic sarcoma of intraabdominal lymph node ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:follicular dendritic sarcoma of intraabdominal lymph node | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:follicular dendritic sarcoma of lymph nodes of multiple sites ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:follicular dendritic sarcoma of lymph nodes of multiple sites | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 1 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 1 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 15 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 15 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 17 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 17 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 19 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 19 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 1q21-31 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 1q21-31 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 20 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 20 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome 22 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome 22 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gain of chromosome x ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gain of chromosome x | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gallbladder leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gallbladder leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ganglioneuroblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ganglioneuroblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:gastric leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:gastric leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:genetic aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:genetic aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:genital rhabdomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:genital rhabdomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:germinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:germinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:giant cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:giant cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:giant cell sarcoma (except of bone, m-92503) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:giant cell sarcoma (except of bone, m-92503) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:glassy cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:glassy cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:glioblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:glioblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:granular cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:granular cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:granulocytic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:granulocytic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:heavy chain disease ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:heavy chain disease | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:hepatoblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:hepatoblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:hepatoid adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:hepatoid adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:high grade serous carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:high grade serous carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:high grade surface osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:high grade surface osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:high risk gastrointestinal stromal tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:high risk gastrointestinal stromal tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:histiocytic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:histiocytic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:historical aspects qualifier ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:historical aspects qualifier | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:hodgkin lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:hodgkin lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:hypereosinophilic syndrome ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:hypereosinophilic syndrome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:idiopathic hypereosinophilic syndrome ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:idiopathic hypereosinophilic syndrome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:immunology aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:immunology aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:in blood ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:in blood | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:in cerebrospinal fluid ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:in cerebrospinal fluid | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:in urine ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:in urine | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:indolent clinical course ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:indolent clinical course | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:indolent systemic mastocytosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:indolent systemic mastocytosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:infantile fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:infantile fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:infiltrating carcinoma with ductal and lobular features ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:infiltrating carcinoma with ductal and lobular features | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:infiltrating duct mixed with other types of carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:infiltrating duct mixed with other types of carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:infiltrating lobular mixed with other types of carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:infiltrating lobular mixed with other types of carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:interdigitating dendritic cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:interdigitating dendritic cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:intermediate filaments present ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:intermediate filaments present | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:intracytoplasmic eosinophilic inclusion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:intracytoplasmic eosinophilic inclusion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:intraductal papillary adenocarcinoma with invasion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:intraductal papillary adenocarcinoma with invasion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:invasive ductal and lobular carcinoma in situ ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:invasive ductal and lobular carcinoma in situ | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:invasive ductal carcinoma, not otherwise specified ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:invasive ductal carcinoma, not otherwise specified | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:invasive micropapillary breast carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:invasive micropapillary breast carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:kaposi sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:kaposi sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:kidney sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:kidney sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:kidney wilms tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:kidney wilms tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:langerhans cell histiocytosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:langerhans cell histiocytosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:langerhans cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:langerhans cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:large cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:large cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:large cell lung carcinoma with rhabdoid phenotype ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:large cell lung carcinoma with rhabdoid phenotype | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:large cell neuroendocrine carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:large cell neuroendocrine carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:laryngeal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:laryngeal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyoma of iris ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyoma of iris | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyomatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyomatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyomatous neoplasm - category ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyomatous neoplasm - category | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma (excluding uterine leiomyosarcoma) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma (excluding uterine leiomyosarcoma) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma - category ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma - category | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse intestinal tract ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse intestinal tract | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse nervous system ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse nervous system | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse nose and paranasal sinuses ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse nose and paranasal sinuses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse oral cavity ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse oral cavity | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse prostate gland ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse prostate gland | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leiomyosarcoma of the mouse skin ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leiomyosarcoma of the mouse skin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lentigo maligna melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lentigo maligna melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leukemia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leukemia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:leukemia (category) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:leukemia (category) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:liposarcoma of connective tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:liposarcoma of connective tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:liver leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:liver leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:liver sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:liver sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lobular breast carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lobular breast carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:low grade central osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:low grade central osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:low grade myofibroblastic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:low grade myofibroblastic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:low grade serous carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:low grade serous carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lung leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lung leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lymphangiosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lymphangiosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lymphosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lymphosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lymphosarcoma of lymph nodes of head, face and neck ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lymphosarcoma of lymph nodes of head, face and neck | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:lymphosarcoma of lymph nodes of multiple sites ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:lymphosarcoma of lymph nodes of multiple sites | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignancy in giant cell tumor of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignancy in giant cell tumor of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant adrenal gland pheochromocytoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant adrenal gland pheochromocytoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant aortic body tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant aortic body tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant blood vessel neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant blood vessel neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant bone marrow neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant bone marrow neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant bone neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant bone neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant carotid body paraganglioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant carotid body paraganglioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant epithelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant epithelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant extra-adrenal paraganglioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant extra-adrenal paraganglioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant giant cell neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant giant cell neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant glioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant glioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant glomus tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant glomus tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant granular cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant granular cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant granulosa cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant granulosa cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant histiocytosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant histiocytosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant immunoproliferative disease (clinical) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant immunoproliferative disease (clinical) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant immunoproliferative neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant immunoproliferative neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant joint neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant joint neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant leydig cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant leydig cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mast cell neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mast cell neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant melanoma in giant pigmented nevus ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant melanoma in giant pigmented nevus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant melanoma in precancerous melanosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant melanoma in precancerous melanosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mesenchymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mesenchymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mesenchymoma metastatic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mesenchymoma metastatic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mesenchymoma recurrent ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mesenchymoma recurrent | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mixed neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mixed neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mixed tumor, carcinomatous type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mixed tumor, carcinomatous type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mixed tumor, chondrosarcomatous type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mixed tumor, chondrosarcomatous type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant mixed tumor, osteosarcomatous type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant mixed tumor, osteosarcomatous type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant muscle neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant muscle neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant musculoskeletal and connective tissue neoplasms ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant musculoskeletal and connective tissue neoplasms | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant myomatous tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant myomatous tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm musculoskeletal ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neoplasm musculoskeletal | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of connective tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neoplasm of connective tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm of nail apparatus ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neoplasm of nail apparatus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neoplasm, overlapping lesion of digestive system ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neoplasm, overlapping lesion of digestive system | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neuroendocrine neoplasm, epithelial ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neuroendocrine neoplasm, epithelial | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neuroendocrine neoplasm, neural ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neuroendocrine neoplasm, neural | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant neuroendocrine tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant neuroendocrine tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant odontogenic ghost cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant odontogenic ghost cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant odontogenic neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant odontogenic neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant ossifying fibromyxoid tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant ossifying fibromyxoid tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant ovarian brenner tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant ovarian brenner tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant ovarian thecoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant ovarian thecoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant pecoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant pecoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant peripheral nerve sheath tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant peripheral nerve sheath tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant peripheral nerve sheath tumor with perineurial differentiation ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant peripheral nerve sheath tumor with perineurial differentiation | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant phyllodes tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant phyllodes tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant sebaceous neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant sebaceous neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant sertoli cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant sertoli cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant smooth muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant smooth muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant soft tissue neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant soft tissue neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant solitary fibrous tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant solitary fibrous tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant spindle cell neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant spindle cell neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant spindle-shaped smooth muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant spindle-shaped smooth muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant squamous cell neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant squamous cell neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant struma ovarii ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant struma ovarii | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant tenosynovial giant cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant tenosynovial giant cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant thymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant thymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant triton tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant triton tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant trophoblastic teratoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant trophoblastic teratoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant tumor, clear cell type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant tumor, clear cell type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant tumor, small cell type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant tumor, small cell type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant type a thymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant type a thymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant type ab thymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant type ab thymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant type b1 thymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant type b1 thymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:malignant type b2 thymoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:malignant type b2 thymoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mast cell malignancy ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mast cell malignancy | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mast cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mast cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mediastinal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mediastinal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:medullary carcinoma with lymphoid stroma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:medullary carcinoma with lymphoid stroma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:medulloblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:medulloblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:medulloepithelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:medulloepithelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:melanoma arising from blue nevus ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:melanoma arising from blue nevus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:melanoma in junctional nevus ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:melanoma in junctional nevus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:meningeal melanomatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:meningeal melanomatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:meningeal sarcomatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:meningeal sarcomatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mesenchymal chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mesenchymal chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mesonephric adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mesonephric adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mesothelioma (malignant, clinical disorder) (disorder) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mesothelioma (malignant, clinical disorder) (disorder) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metabolic aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metabolic aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metaplastic carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metaplastic carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastases to muscle ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastases to muscle | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastases to perineum ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastases to perineum | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastasis to lymph node from adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastasis to lymph node from adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastasis to lymph node from squamous cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastasis to lymph node from squamous cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastasizing ameloblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastasizing ameloblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastasizing leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastasizing leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic alveolar soft part sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic alveolar soft part sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic epithelioid sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic epithelioid sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic extraskeletal ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic extraskeletal ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic extraskeletal osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic extraskeletal osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic malignant neoplasm in the bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic malignant neoplasm in the bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic malignant neoplasm in the chest wall ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic malignant neoplasm in the chest wall | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic malignant neoplasm in the neck ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic malignant neoplasm in the neck | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic malignant neoplasm in the spine ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic malignant neoplasm in the spine | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic malignant peripheral nerve sheath tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic malignant peripheral nerve sheath tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic peripheral primitive neuroectodermal tumor of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic peripheral primitive neuroectodermal tumor of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic qualifier ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic qualifier | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic synovial sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic synovial sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:metastatic undifferentiated pleomorphic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:metastatic undifferentiated pleomorphic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:microbiological ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:microbiological | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:microcystic adnexal carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:microcystic adnexal carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:micropapillary transitional cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:micropapillary transitional cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:minimal deviation malignant melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:minimal deviation malignant melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed acinar-ductal carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed acinar-ductal carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed epithelioid and spindle cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed epithelioid and spindle cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed germ cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed germ cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed glioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed glioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed mesodermal (mullerian) tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed mesodermal (mullerian) tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed tumor, mesodermal ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed tumor, mesodermal | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mixed type rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mixed type rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mouse leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mouse leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mucin-producing adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mucin-producing adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mucoepidermoid carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mucoepidermoid carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:mucosal lentiginous melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:mucosal lentiginous melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:muscle tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:muscle tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:muscle tumor, special type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:muscle tumor, special type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:muscle tumors (all subtypes) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:muscle tumors (all subtypes) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myelodysplastic syndrome with isolated del(5q) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myelodysplastic syndrome with isolated del(5q) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myelodysplastic syndrome, no icd-o subtype ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myelodysplastic syndrome, no icd-o subtype | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myeloid sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myeloid sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myeloliposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myeloliposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myeloproliferative neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myeloproliferative neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myofibroma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myofibroma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myogenic sarcoma, nos ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myogenic sarcoma, nos | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myolipoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myolipoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myomatous neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myomatous neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myxofibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myxofibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myxoid chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myxoid chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myxoid leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myxoid leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myxoid liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myxoid liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:myxosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:myxosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nci ctep sdc non-rhabdomyosarcoma soft tissue sarcoma sub-category terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nci ctep sdc non-rhabdomyosarcoma soft tissue sarcoma sub-category terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nci ctep simplified disease classification terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nci ctep simplified disease classification terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ncit neoplasm core terminology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ncit neoplasm core terminology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplasm of uncertain behavior of muscle ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplasm of uncertain behavior of muscle | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplasms, muscle tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplasms, muscle tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplastic cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplastic cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplastic connective and soft tissue cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplastic connective and soft tissue cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplastic muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplastic muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neoplastic smooth muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neoplastic smooth muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neuroblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neuroblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neuroepithelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neuroepithelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:neuron, neuroepithelial cell, and supporting cell of the nervous system ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:neuron, neuroepithelial cell, and supporting cell of the nervous system | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nodular melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nodular melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:non-hodgkin lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:non-hodgkin lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:non-keratinizing sinonasal squamous cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:non-keratinizing sinonasal squamous cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:non-small cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:non-small cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nonseminomatous germ cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nonseminomatous germ cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nursing therapy ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nursing therapy | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:nutritional management ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:nutritional management | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:olfactory neurogenic tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:olfactory neurogenic tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:oligodendroglioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:oligodendroglioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:oral cavity leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:oral cavity leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ovarian dermoid cyst with leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ovarian dermoid cyst with leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:overlapping malignant melanoma of skin ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:overlapping malignant melanoma of skin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:overlapping malignant neoplasm of gastrointestinal tract ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:overlapping malignant neoplasm of gastrointestinal tract | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:overlapping malignant neoplasm of ill-defined site ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:overlapping malignant neoplasm of ill-defined site | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:overlapping malignant neoplasm of lip, oral cavity and pharynx ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:oxyphilic adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:oxyphilic adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:paget disease and intraductal carcinoma of the breast ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:paget disease and intraductal carcinoma of the breast | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:paget's disease and infiltrating duct carcinoma of breast ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:paget's disease and infiltrating duct carcinoma of breast | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pancreatic acinar cell cystadenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pancreatic acinar cell cystadenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pancreatoblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pancreatoblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:papillary meningioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:papillary meningioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:papillary transitional cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:papillary transitional cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:parasitic fibroid ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:parasitic fibroid | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:parasitology ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:parasitology | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:parosteal osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:parosteal osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pathological aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pathological aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pericardial leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pericardial leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:periosteal chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:periosteal chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:periosteal fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:periosteal fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:periosteal osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:periosteal osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:peripheral primitive neuroectodermal tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:peripheral primitive neuroectodermal tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:peripheral primitive neuroectodermal tumor of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:peripheral primitive neuroectodermal tumor of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:peripheral primitive neuroectodermal tumor of soft tissues ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:peripheral primitive neuroectodermal tumor of soft tissues | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pharmacotherapeutic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pharmacotherapeutic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:phyllodes tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:phyllodes tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:physiopathological ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:physiopathological | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pilomatrical carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pilomatrical carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:plasma cell myeloma/plasmacytoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:plasma cell myeloma/plasmacytoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pleomorphic liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pleomorphic liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pleomorphic rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pleomorphic rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pleuropulmonary blastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pleuropulmonary blastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:polycythemia vera ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:polycythemia vera | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:polyembryoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:polyembryoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:polygonal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:polygonal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:polymorphous low grade adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:polymorphous low grade adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:poorly differentiated carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:poorly differentiated carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:poorly differentiated sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:poorly differentiated sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary broad ligament fibroid ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary broad ligament fibroid | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant adenomatous neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant adenomatous neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of articular cartilage ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of articular cartilage | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of back ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of back | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of ear, nose and/or throat ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of ear, nose and/or throat | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of endocrine gland ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of endocrine gland | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of gastrointestinal tract ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of gastrointestinal tract | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of head ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of head | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of ill-defined site ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of ill-defined site | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of independent multiple sites ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of independent multiple sites | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of lower limb ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of lower limb | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of muscle ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of muscle | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of neck ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of neck | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of nervous system ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of nervous system | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of paraganglion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of paraganglion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of respiratory tract ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of respiratory tract | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of soft tissues ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of soft tissues | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of sweat gland ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of sweat gland | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of trunk ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of trunk | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of unknown site ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of unknown site | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of unspecified site (clinical) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of unspecified site (clinical) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary malignant neoplasm of upper limb (disorder) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary malignant neoplasm of upper limb (disorder) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary myelofibrosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary myelofibrosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primary undifferentiated large cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primary undifferentiated large cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:primitive neuroectodermal tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:primitive neuroectodermal tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:prolymphocytic lymphosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:prolymphocytic lymphosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:prostate leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:prostate leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:pseudoglandular squamous cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:pseudoglandular squamous cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:psychology qualifier ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:psychology qualifier | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:radiation-related sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:radiation-related sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:radiotherapeutic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:radiotherapeutic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rb1 gene ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rb1 gene | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rb1 wt allele ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rb1 wt allele | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:reactive immunoproliferative disease ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:reactive immunoproliferative disease | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent alveolar soft part sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent alveolar soft part sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent chondrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent chondrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent epithelioid sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent epithelioid sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent extraskeletal ewing sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent extraskeletal ewing sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent extraskeletal osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent extraskeletal osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent malignant mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent malignant mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent malignant peripheral nerve sheath tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent malignant peripheral nerve sheath tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent peripheral primitive neuroectodermal tumor of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent peripheral primitive neuroectodermal tumor of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent synovial sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent synovial sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:recurrent undifferentiated pleomorphic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:recurrent undifferentiated pleomorphic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory anemia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory anemia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory anemia with excess blasts ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory anemia with excess blasts | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory anemia with excess blasts in transformation ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory anemia with excess blasts in transformation | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory anemia with ring sideroblasts ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory anemia with ring sideroblasts | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory cytopenia with multilineage dysplasia ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory cytopenia with multilineage dysplasia | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:refractory cytopenia with multilineage dysplasia and ring sideroblasts ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:regressed germ cell tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:regressed germ cell tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:regressing melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:regressing melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rehabilitation aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rehabilitation aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:retroperitoneal sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:retroperitoneal sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rhabdoid tumor ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rhabdoid tumor | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rhabdomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rhabdomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rhabdomyomatous neoplasm - category ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rhabdomyomatous neoplasm - category | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:roentgenographic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:roentgenographic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:round cell liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:round cell liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:round ligament fibroid ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:round ligament fibroid | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma by ajcc grade ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma by ajcc grade | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma by fnclcc grade ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma by fnclcc grade | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma by nci grade ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma by nci grade | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma of back ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma of back | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma of head and neck ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma of head and neck | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma of pelvis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma of pelvis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma of posterior mediastinum ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma of posterior mediastinum | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma, experimental ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma, experimental | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcoma, metastatic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcoma, metastatic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcomatoid carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcomatoid carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcomatoid mesothelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcomatoid mesothelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcomatoid squamous cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcomatoid squamous cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcomatoid transitional cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcomatoid transitional cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sarcomatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sarcomatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:second primary malignant neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:second primary malignant neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:secondary malignant neoplasm of soft tissues ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:secondary malignant neoplasm of soft tissues | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:secondary osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:secondary osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:secretory breast carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:secretory breast carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:seromucinous carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:seromucinous carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sertoli cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sertoli cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sertoli-leydig cell tumor, poorly differentiated ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sertoli-leydig cell tumor, poorly differentiated | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:signet ring cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:signet ring cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skeletal muscle neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skeletal muscle neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin adenoid basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin adenoid basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin basosquamous cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin basosquamous cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin fibroepithelial basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin fibroepithelial basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin infiltrating basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin infiltrating basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin metatypical carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin metatypical carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin nodular basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin nodular basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:skin sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:skin sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell carcinoma carcinomatosis ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell carcinoma carcinomatosis | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell carcinoma, fusiform cell type ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell carcinoma, fusiform cell type | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell intermediate cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell intermediate cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small intestinal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small intestinal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:small intestinal leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:small intestinal leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:smooth muscle cell ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:smooth muscle cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:smooth muscle neoplasm ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:smooth muscle neoplasm | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:smooth muscle tissue ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:smooth muscle tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:smooth muscle tumor of uncertain malignant potential ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:smooth muscle tumor of uncertain malignant potential | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:soft tissue neoplasms malignant and unspecified ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:soft tissue neoplasms malignant and unspecified | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:soft tissue neoplasms malignant and unspecified nec (excl sarcomas) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:soft tissue sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:soft tissue sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:soft tissue sarcomas histology unspecified ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:soft tissue sarcomas histology unspecified | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:solid papillary carcinoma with invasion ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:solid papillary carcinoma with invasion | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:solid pseudopapillary carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:solid pseudopapillary carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:spindle cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:spindle cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:spindle cell rhabdomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:spindle cell rhabdomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:spindle cell sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:spindle cell sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:spiradenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:spiradenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:spongioneuroblastoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:spongioneuroblastoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:steroid cell tumor, malignant ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:steroid cell tumor, malignant | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:storiform-pleomorphic malignant fibrous histiocytoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:storiform-pleomorphic malignant fibrous histiocytoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:stromal sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:stromal sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:superficial multifocal basal cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:superficial multifocal basal cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:superficial spreading melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:superficial spreading melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:surgical aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:surgical aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:sweat gland adenocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:sweat gland adenocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:synovial sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:synovial sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:synovial sarcoma - category ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:synovial sarcoma - category | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:t lymphoblastic leukemia/lymphoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:t lymphoblastic leukemia/lymphoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:taxonomic ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:taxonomic | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:telangiectatic osteosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:telangiectatic osteosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:teratoid medulloepithelioma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:teratoid medulloepithelioma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:testicular leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:testicular leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:testicular spermatocytic seminoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:testicular spermatocytic seminoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:therapeutic aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:therapeutic aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:therapy-related myelodysplastic syndrome ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:therapy-related myelodysplastic syndrome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:thymic carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:thymic carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:thymoma type b3 ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:thymoma type b3 | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:thyroid gland carcinoma showing thymus-like differentiation ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:thyroid gland carcinoma showing thymus-like differentiation | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:thyroid gland diffuse sclerosing papillary carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:thyroid gland diffuse sclerosing papillary carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:thyroid gland spindle cell tumor with thymus-like differentiation ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:thyroid gland spindle cell tumor with thymus-like differentiation | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:tracheal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:tracheal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:transitional cell carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:transitional cell carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:trichilemmocarcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:trichilemmocarcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:type a spindle cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:type a spindle cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:type b spindle cell melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:type b spindle cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ultrastructure ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ultrastructure | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated (embryonal) sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated (embryonal) sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated high grade pleomorphic sarcoma of bone ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated high grade pleomorphic sarcoma of bone | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated pleomorphic sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated pleomorphic sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated pleomorphic sarcoma, inflammatory variant ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated pleomorphic sarcoma, inflammatory variant | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:undifferentiated sarcoma, not otherwise specified ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:undifferentiated sarcoma, not otherwise specified | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:ureter leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:ureter leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:urethral leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:urethral leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:use of ultrasonography ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:use of ultrasonography | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:uterine corpus leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:uterine corpus leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:uterine corpus leiomyosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:uterine corpus leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:vaccine-induced fibrosarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:vaccine-induced fibrosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:vaginal leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:vaginal leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:verrucous carcinoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:verrucous carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:veterinary aspects ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:veterinary aspects | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:viruses ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:viruses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:vulvar leiomyoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:vulvar leiomyoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:vulvar sarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:vulvar sarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- en:well differentiated liposarcoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=en:well differentiated liposarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- maladie ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=maladie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- maladie grave ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=maladie grave | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- maladies ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=maladies | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- melanoma ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- muscle ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=muscle | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- muscle lisse ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=muscle lisse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- médecine ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=médecine | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- médecine spécialisée ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=médecine spécialisée | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- médecine
(science) ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=médecine (science) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- oncologie ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=oncologie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- pathologie ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=pathologie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- poumon ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=poumon | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- processus pathologique ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=processus pathologique | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- sarcome ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=sarcome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- spécialités médicales ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=spécialités médicales | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tissu conjonctif ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tissu conjonctif | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tumeur ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tumeur | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tumeur du tissu musculaire ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tumeur du tissu musculaire | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tumeur maligne ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tumeur maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tumeur mésenchymateuse maligne ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tumeur mésenchymateuse maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- tumeurs ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=tumeurs | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- utérus ---
r_associated #0: 20 -->
en:lelomyosarcoma
n1=utérus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
- Cancer osseux ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=Cancer osseux | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- carcinoma ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=carcinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- carcinome acineux ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=carcinome acineux | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- carcinome glandulaire et malpighien ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=carcinome glandulaire et malpighien | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- carcinome mixte glandulaire et spinocellulaire ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=carcinome mixte glandulaire et spinocellulaire | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- en:tumour ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=en:tumour | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- fibroxanthome malin ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=fibroxanthome malin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- histiocytome fibreux malin stade non spécifié ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=histiocytome fibreux malin stade non spécifié | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- hystiocytose à cellules de langerhans ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=hystiocytose à cellules de langerhans | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- lymphome malin diffus ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=lymphome malin diffus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- lymphome à cellules b ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=lymphome à cellules b | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocyte des muscles lisses ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocyte des muscles lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocyte du muscle lisse ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocyte du muscle lisse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocytes de muscles lisses ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocytes de muscles lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocytes des muscles lisses ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocytes des muscles lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocytes du muscle lisse ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocytes du muscle lisse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- myocytes lisses ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=myocytes lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- sarcome granulocytaire ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=sarcome granulocytaire | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- tumeur maligne des os ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=tumeur maligne des os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- tumeur maligne osseuse ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=tumeur maligne osseuse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- tumeur neuroectodermique périphérique primitive ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=tumeur neuroectodermique périphérique primitive | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- tumeur primitive neuroectodermique ---
r_associated #0: 15 -->
en:lelomyosarcoma
n1=tumeur primitive neuroectodermique | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=15
- Cancérologie ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=Cancérologie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- Leiner-Moussous (syndrome de) ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=Leiner-Moussous (syndrome de) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- acral lentiginous melanoma ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=acral lentiginous melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- balloon cell melanoma ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=balloon cell melanoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- cancer des os ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=cancer des os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- carcinome adéno-squameux ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=carcinome adéno-squameux | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- carcinome mixte glandulaire et épidermoïde ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=carcinome mixte glandulaire et épidermoïde | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- cellule tumorale ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=cellule tumorale | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- en:connective tissue ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=en:connective tissue | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- en:histiocytosis, langerhans-cell ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=en:histiocytosis, langerhans-cell | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- en:uterus ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=en:uterus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- grave maladie ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=grave maladie | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- histiocytofibrome malin ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=histiocytofibrome malin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- histiocytome malin ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=histiocytome malin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- histiocytose à cellules de langerhans ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=histiocytose à cellules de langerhans | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- lymphome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=lymphome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- lymphome malin non hodgkinien ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=lymphome malin non hodgkinien | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- lymphome malin à cellules à noyaux non encochés ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=lymphome malin à cellules à noyaux non encochés | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- lymphome non hodgkinien ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=lymphome non hodgkinien | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- lymphomes non hodgkiniens ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=lymphomes non hodgkiniens | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- malignité dans la tumeur à cellules géantes de l'os ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=malignité dans la tumeur à cellules géantes de l'os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- melanomalignom ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=melanomalignom | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- myélofibrose primaire ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=myélofibrose primaire | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- myélofibrose primitive ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=myélofibrose primitive | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- médulloépithéliome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=médulloépithéliome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- médulloépithéliome tératoïde ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=médulloépithéliome tératoïde | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- mélanome à cellules fusiformes ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=mélanome à cellules fusiformes | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- mélanome à cellules fusiformes de type b ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=mélanome à cellules fusiformes de type b | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- naevocarcinome à cellules fusiformes ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=naevocarcinome à cellules fusiformes | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- naevocarcinome à cellules fusiformes de type b ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=naevocarcinome à cellules fusiformes de type b | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- neuro-épithéliome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=neuro-épithéliome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- neuroépithéliome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=neuroépithéliome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- polycythemia vera ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=polycythemia vera | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- polyembryome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=polyembryome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- rhabdomyosarcome ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=rhabdomyosarcome | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- rhabdomyosarcomes ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=rhabdomyosarcomes | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- sarcome des tissus mous ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=sarcome des tissus mous | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur cancéreuse ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur cancéreuse | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur de Brenner ovarienne maligne ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur de Brenner ovarienne maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur de Wilms du rein ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur de Wilms du rein | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur fibromyxoïde ossifiante maligne ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur fibromyxoïde ossifiante maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur germinale mixte ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur germinale mixte | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne de Triton ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne de Triton | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne de la gaine des nerfs périphériques avec différenciation périneurale ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne de la gaine des nerfs périphériques avec différenciation périneurale | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne du corps aortique ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne du corps aortique | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne métastatique de la gaine des nerfs périphériques ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne métastatique de la gaine des nerfs périphériques | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne récurrente de la gaine des nerfs périphériques ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne récurrente de la gaine des nerfs périphériques | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne à cellules de Leydig ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne à cellules de Leydig | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur maligne à cellules de la granulosa ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur maligne à cellules de la granulosa | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur myomateuse maligne ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur myomateuse maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neuroectodermique primitive périphérique de l'os ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neuroectodermique primitive périphérique de l'os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neuroectodermique primitive périphérique des tissus mous ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neuroectodermique primitive périphérique des tissus mous | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neuroectodermique primitive périphérique métastatique de l'os ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neuroectodermique primitive périphérique métastatique de l'os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neuroectodermique primitive périphérique récurrente de l'os ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neuroectodermique primitive périphérique récurrente de l'os | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neuroendocrine maligne ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neuroendocrine maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur neurogène olfactive ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur neurogène olfactive | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur odontogène maligne à cellules fantômes ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur odontogène maligne à cellules fantômes | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur ténosynoviale à cellules géantes maligne ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur ténosynoviale à cellules géantes maligne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur à cellules fusiformes de la glande thyroïde avec différenciation thymus-like ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur à cellules fusiformes de la glande thyroïde avec différenciation thymus-like | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- tumeur à cellules germinales régressive ---
r_associated #0: 10 -->
en:lelomyosarcoma
n1=tumeur à cellules germinales régressive | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=10
- léiomyosarcome myxoïde ---
r_associated #0: 7 -->
en:lelomyosarcoma
n1=léiomyosarcome myxoïde | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=7
- en:myxoid leiomyosarcoma ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=en:myxoid leiomyosarcoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- leiomyosarcome rénal ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=leiomyosarcome rénal | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- leiomyosarcome testiculaire ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=leiomyosarcome testiculaire | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome cutané ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome cutané | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome de l'intestin grêle ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome de l'intestin grêle | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome de l'utérus ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome de l'utérus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome du côlon ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome du côlon | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome métastatique ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome métastatique | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome non métastasique ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome non métastasique | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome récidivant ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome récidivant | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- léiomyosarcome épithélioïde ---
r_associated #0: 6 -->
en:lelomyosarcoma
n1=léiomyosarcome épithélioïde | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=6
- Maladie grave ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=Maladie grave | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- Spécialités médicales ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=Spécialités médicales | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- Tissu conjonctif ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=Tissu conjonctif | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- USUV ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=USUV | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- Utérus ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=Utérus | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- carcinome adénosquameux ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=carcinome adénosquameux | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- cellule épithéliale ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=cellule épithéliale | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- en:smooth muscle (tissue) ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=en:smooth muscle (tissue) | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- histiocytose langerhansienne ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=histiocytose langerhansienne | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- histiocytose à cellules de Langerhans ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=histiocytose à cellules de Langerhans | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- myocyte de muscles lisses ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=myocyte de muscles lisses | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- myome utérin ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=myome utérin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- sarcome a petites cellules ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=sarcome a petites cellules | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- sarcome à petites cellules ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=sarcome à petites cellules | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- tumeur neuro-ectodermique primitive ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=tumeur neuro-ectodermique primitive | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
- épithélioma malin ---
r_associated #0: 5 -->
en:lelomyosarcoma
n1=épithélioma malin | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=5
|